<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Database (Oxford)</journal-id>
    <journal-id journal-id-type="iso-abbrev">Database (Oxford)</journal-id>
    <journal-id journal-id-type="publisher-id">databa</journal-id>
    <journal-title-group>
      <journal-title>Database: The Journal of Biological Databases and Curation</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-0463</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
      <publisher-loc>UK</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10563827</article-id>
    <article-id pub-id-type="doi">10.1093/database/baad063</article-id>
    <article-id pub-id-type="publisher-id">baad063</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Database Tool</subject>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00960</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Sindhoo</surname>
          <given-names>Asma</given-names>
        </name>
        <aff><institution content-type="department">Department of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University</institution>, Dongchuan Road Minhang District, Shanghai 200240, <country country="CN">PR China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sipy</surname>
          <given-names>Saima</given-names>
        </name>
        <aff><institution>Sindh Madressatul Islam University</institution>, Karachi, Sindh 74600, <country country="PK">Pakistan</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4288-7602</contrib-id>
        <name>
          <surname>Khan</surname>
          <given-names>Abbas</given-names>
        </name>
        <!--abbaskhan@sjtu.edu.cn-->
        <xref rid="COR0001" ref-type="corresp"/>
        <aff><institution content-type="department">Department of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University</institution>, Dongchuan Road Minhang District, Shanghai 200240, <country country="CN">PR China</country></aff>
        <aff><institution content-type="department">State Key Laboratory of Microbial Metabolism, Shanghai–Islamabad–Belgrade Joint Innovation Center on Antibacterial Resistances, Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education and School of Life Sciences and Biotechnology</institution>, Shanghai, Minhang 200030, <country country="CN">PR China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Selvaraj</surname>
          <given-names>Gurudeeban</given-names>
        </name>
        <aff><institution content-type="department">Centre for Research in Molecular Modelling (CERMM), Department of Chemistry and Biochemistry, Concordia University</institution>, Montreal, Quebec H4B 1R6, <country country="CA">Canada</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Alshammari</surname>
          <given-names>Abdulrahman</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University</institution>, Riyadh 11451, <country country="SA">Saudi Arabia</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Casida</surname>
          <given-names>Mark Earl</given-names>
        </name>
        <aff><institution content-type="department">Laboratoire de Spectrom´etrie, Interactions et Chimie th´eorique (SITh), D´epartement de Chimie Mol´eculaire (DCM, UMR CNRS/UGA 5250), Institut de Chimie Mol´eculaire de Grenoble (ICMG, FR2607), Universit´e Grenoble Alpes (UGA)</institution>, 301 rue de la Chimie BP 53, Grenoble Cedex F-38041, <country country="FR">France</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Wei</surname>
          <given-names>Dong-Qing</given-names>
        </name>
        <!--dqwei@sjtu.edu.cn-->
        <aff><institution content-type="department">Department of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University</institution>, Dongchuan Road Minhang District, Shanghai 200240, <country country="CN">PR China</country></aff>
        <aff><institution content-type="department">State Key Laboratory of Microbial Metabolism, Shanghai–Islamabad–Belgrade Joint Innovation Center on Antibacterial Resistances, Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education and School of Life Sciences and Biotechnology</institution>, Shanghai, Minhang 200030, <country country="CN">PR China</country></aff>
        <aff><institution>Peng Cheng Laboratory</institution>, Phase I Building 8, Xili Street, Montreal, Vanke Cloud City, Nashan District, Shenzhen, Guangdong 518055, <country country="CN">PR China</country></aff>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR0001">*Corresponding author: Tel: +8613482132323; Email: <email xlink:href="abbaskhan@sjtu.edu.cn">abbaskhan@sjtu.edu.cn</email>Correspondence may also be addressed to Dong-Qing Wei. Email: <email xlink:href="dqwei@sjtu.edu.cn">dqwei@sjtu.edu.cn</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2023-10-10">
      <day>10</day>
      <month>10</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>10</day>
      <month>10</month>
      <year>2023</year>
    </pub-date>
    <volume>2023</volume>
    <elocation-id>baad063</elocation-id>
    <history>
      <date date-type="received">
        <day>12</day>
        <month>5</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>10</day>
        <month>7</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>16</day>
        <month>9</month>
        <year>2023</year>
      </date>
      <date date-type="editorial-decision">
        <day>04</day>
        <month>8</month>
        <year>2023</year>
      </date>
      <date date-type="corrected-typeset">
        <day>10</day>
        <month>10</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="baad063.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>‘Esophageal cancer’ (EC) is a highly aggressive and deadly complex disease. It comprises two types, esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC), with Barrett’s esophagus (BE) being the only known precursor. Recent research has revealed that microRNAs (miRNAs) play a crucial role in the development, prognosis and treatment of EC and are involved in various human diseases. Biological databases have become essential for cancer research as they provide information on genes, proteins, pathways and their interactions. These databases collect, store and manage large amounts of molecular data, which can be used to identify patterns, predict outcomes and generate hypotheses. However, no comprehensive database exists for EC and miRNA relationships. To address this gap, we developed a dynamic database named ‘ESOMIR (miRNA in esophageal cancer) (<ext-link xlink:href="https://esomir.dqweilab-sjtu.com" ext-link-type="uri">https://esomir.dqweilab-sjtu.com</ext-link>)’, which includes information about targeted genes and miRNAs associated with EC. The database uses analysis and prediction methods, including experimentally endorsed miRNA(s) information. ESOMIR is a user-friendly interface that allows easy access to EC-associated data by searching for miRNAs, target genes, sequences, chromosomal positions and associated signaling pathways. The search modules are designed to provide specific data access to users based on their requirements. Additionally, the database provides information about network interactions, signaling pathways and region information of chromosomes associated with the 3ʹuntranslated region (3ʹUTR) or 5ʹUTR and exon sites. Users can also access energy levels of specific miRNAs with targeted genes. A fuzzy term search is included in each module to enhance the ease of use for researchers. ESOMIR can be a valuable tool for researchers and clinicians to gain insight into EC, including identifying biomarkers and treatments for this aggressive tumor.</p>
      <p>
        <bold>Database URL</bold>
        <ext-link xlink:href="https://esomir.dqweilab-sjtu.com" ext-link-type="uri">https://esomir.dqweilab-sjtu.com</ext-link>
      </p>
    </abstract>
    <counts>
      <page-count count="12"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec id="s1">
    <title>Introduction</title>
    <p>Esophageal cancer (EC) is one of the deadliest cancers. In 2020, EC was responsible for 0.54 million deaths with 0.6 million new cases worldwide according to Global Cancer Statistics 2020: GLOBOCAN estimation (<xref rid="R1" ref-type="bibr">1</xref>). Histologically, in EC, there are two subtypes: esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC) (<xref rid="R2" ref-type="bibr">2</xref>). However, it is believed that Barrett’s esophagus (BE) is the only precursor to EAC (<xref rid="R3" ref-type="bibr">3</xref>). Both subtypes seem very different due to distinctive primary risks, time trends, geographical patterns and genetic associations (<xref rid="R4" ref-type="bibr">4</xref>). The multistep process of EC development (ESCC and EAC) involves genetic occurrences that lead to important abnormalities in cell cycle control, neurotrophic interaction and adhesion molecules mechanisms (<xref rid="R5" ref-type="bibr">5</xref>). The occurrence of ESCC is predominant in Asian and sub-Sahara African regions, while EAC is predominant in Western countries (<xref rid="R1" ref-type="bibr">1</xref>).</p>
    <p>MicroRNAs (miRNAs) are short [18–24 nucleotides (nt)] intrinsic non-coding RNAs that could control the gene transcription, i.e. pre-regulation of genes. miRNAs are a set of smallest single-stranded non-coding molecules among its other types, with 21–25 nt that regulate genes post-transcription in various species (<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R7" ref-type="bibr">7</xref>). miRNA plays a key role in regulating biological, physiological and cellular developmental processes, including apoptosis, cell proliferation, differentiation, invasion, metastasis, metabolism, tumorigenic progression, resisting cell death and stem cell maintenance (<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R9" ref-type="bibr">9</xref>). miRNA is the crucial player that can act as a tumor suppressor or oncogenes after being downregulated or upregulated (<xref rid="R10" ref-type="bibr">10</xref>). In a recent study, most miRNA gene mutations are typically found in genomic regions linked to cancer (<xref rid="R11" ref-type="bibr">11</xref>). Unfortunately, EC (subtypes ESCC and EAC) is diagnosed at an advanced or metastatic stage in most cases due to its asymptomatic nature, resulting in a poor prognosis and a high-death rate (<xref rid="R12" ref-type="bibr">12</xref>).</p>
    <p>Recent advancement in tumorigenesis shows that molecular mechanism studies play a vital role in understanding insight into cancer (<xref rid="R13" ref-type="bibr">13</xref>). Molecular biomarkers are potential solutions for improving cancer invasion, metastasis and prognosis (<xref rid="R14" ref-type="bibr">14–16</xref>). miRNAs seem revolutionary discoveries for cancer treatment as miRNA acts as a regulator of gene expression. miRNA target identification has been a prominent area of research in recent years to gain insights into the signaling pathways, genes and mechanisms involved in cancer (<xref rid="R17" ref-type="bibr">17–21</xref>). miRNA prediction in vertebrates is complex as they have irregular homology in the target sequence on the seed region (<xref rid="R22" ref-type="bibr">22</xref>). There is substantial evidence that miRNAs play a critical role in the development of EC (<xref rid="R23" ref-type="bibr">23–26</xref>). miRNAs have also been utilized to classify EC based on the stage or type (<xref rid="R27" ref-type="bibr">27</xref>).</p>
    <p>MiRNAs identified through computational methods and subsequently validated through experimental methods have the highest potential to alleviate the underlying mechanisms involved in cancer hallmarks. Several miRNA discoveries associated with EC networks have shown promising results for prognosis, diagnosis and treatment. There is a growing demand for a user-friendly knowledge repository containing all relevant information, including miRNAs, genes, pathways, targets, networks and more (<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R7" ref-type="bibr">7</xref>).</p>
    <p>Several databases are available to provide chromosomal-based information associated with targeted messenger RNA (mRNA), cancer pathways and lists of miRNAs. Some comprehensive databases, such as miRBase (<xref rid="R28" ref-type="bibr">28</xref>), miRGen v.3 (<xref rid="R29" ref-type="bibr">29</xref>) and MiRGator v 3.0 (<xref rid="R30" ref-type="bibr">30</xref>), provide annotated sequences, nomenclature and target information. Manually curated databases, including miRWalk (<xref rid="R31" ref-type="bibr">31</xref>), miRTarbase (<xref rid="R32" ref-type="bibr">32</xref>), miRNAMap (<xref rid="R33" ref-type="bibr">33</xref>) and mirRecord (<xref rid="R34" ref-type="bibr">34</xref>), offer experimentally validated perspectives on associated miRNAs, their interactions and targets. Additionally, there are computationally targeted prediction-based databases, such as TargetScan (<xref rid="R35" ref-type="bibr">35</xref>), miRDB (<xref rid="R36" ref-type="bibr">36</xref>), PicTar (<xref rid="R37" ref-type="bibr">37</xref>) and MirRabel (<xref rid="R38" ref-type="bibr">38</xref>). Several disease-specific databases exist to fulfill the needs of miRNA repositories, such as OncomiRdbB (<xref rid="R39" ref-type="bibr">39</xref>), miRCancer (<xref rid="R40" ref-type="bibr">40</xref>), miRactDB (<xref rid="R41" ref-type="bibr">41</xref>), PhenoMir (<xref rid="R42" ref-type="bibr">42</xref>), HDMM (<xref rid="R43" ref-type="bibr">43</xref>) and S-MED (<xref rid="R44" ref-type="bibr">44</xref>). However, these databases focus on different cancer types and provide detailed information about those diseases. Unfortunately, no detailed repository is available to provide insightful information about miRNAs involved in EC and its subtypes. Therefore, we developed and designed a comprehensive miRNA-based repository for researchers to access mRNA–miRNA targets, signaling pathways and targeted gene ontologies for EC. We created a web-based repository/database with a graphical user interface called ESOMIR (<ext-link xlink:href="https://esomir.dqweilab-sjtu.com" ext-link-type="uri">https://esomir.dqweilab-sjtu.com</ext-link>). Our database contains 877 human miRNAs and 133 mRNAs that act as miRNA targets in various signaling pathways, and we used MirWalk and TargetScan to cross-validate the putative targets for miRNAs. ESOMIR is a promising tool for the diagnostic paradigm in EC as it is a unique, comprehensive data repository freely accessible to everyone.</p>
  </sec>
  <sec id="s2">
    <title>Database design and structure</title>
    <sec id="s2-s1">
      <title>Quarrying and categorizing miRNAs and their associated targets</title>
      <p>We mined all miRNAs from literature and various databases, specifically MirTarbase, MiRDB, miRBase, MicroCosm, miR2Disease (<xref rid="R45" ref-type="bibr">45</xref>) and miRSystem (<xref rid="R46" ref-type="bibr">46</xref>). We wrote a function in Python to exclude duplicated entries and used a script to acquire all mature miRNA FASTA sequences from miRBase. We extracted the targeted sites (3′UTRs, 5′UTRs and exons) of oncogenes from literature and knowledge systems such as COSMIC (Catalogue of Somatic Mutations in Cancer) (<xref rid="R47" ref-type="bibr">47</xref>), KEGG (Kyoto Encyclopedia of Genes and Genomes) (<xref rid="R48" ref-type="bibr">48</xref>), DDEC (Dragon Database of Genes Implicated in Esophageal Cancer) (<xref rid="R49" ref-type="bibr">49</xref>), CGED (Cancer Gene Expression Database) (<xref rid="R50" ref-type="bibr">50</xref>) and DisGenNet (<xref rid="R51" ref-type="bibr">51</xref>). We used the Ensembl-BioMart tool (<xref rid="R52" ref-type="bibr">52</xref>) to download the FASTA sequence of all oncogenes. Then, we screened 2654 miRNAs against EC oncogenes using miRanda (<xref rid="R53" ref-type="bibr">53</xref>), DIANA-microT-CDS (<xref rid="R54" ref-type="bibr">54</xref>) and RNA22 v2. We identified potential miRNAs and their target sites based on the standard scores set for an appropriate target. After the screening, we used the KEGG database to find signaling pathways against each putative target. We illustrated the complete workflow from data mining to processing, prediction and validation used in the study in <xref rid="F1" ref-type="fig">Figure 1</xref>.</p>
      <fig position="float" id="F1" fig-type="figure">
        <label>Figure 1.</label>
        <caption>
          <p>This diagram illustrates the ESOMIR modules, representing data analysis, prediction and mining procedures. Each stage in the process is clearly defined in this schematic, outlining the steps taken to reach the desired outcome.</p>
        </caption>
        <graphic xlink:href="baad063f1" position="float"/>
      </fig>
    </sec>
    <sec id="s2-s2">
      <title>The structure of database and its contents</title>
      <p>Database development is complex when providing a cognate database to users via a web-based interface with processing accuracy and speed. We developed and designed a database structure that allows users to access and extract information about miRNAs and their targets for human EC. We designed and developed ESOMIR as a cloud-based web portal to give access to in-depth analyzed data. The user interface of ESOMIR is user-friendly, which allows easy access to efficient information. We designed the structure of ESOMIR using PHP, MySQL, HTML, DataTables, Ajax, Bootstrap and jQuery.</p>
      <sec id="s2-s2-s1">
        <title>Back-end development</title>
        <p>We used the XAMPP server to design a cloud-based online portal, integrating parts such as Apache server, database (MySQL) and web interface. We developed the online portal using two scripting languages (PHP and HTML). We used MySQL and DataTables for data storage and associated operations. Additionally, we implemented logical scripts to search miRNAs, target genes or associated pathways to EC to develop the data extraction module (<xref rid="F1" ref-type="fig">Figure 1</xref>). ESOMIR is directly linked to an original database, allowing users to access direct data. ESOMIR offers multiple particulars to access data associated with EC, including miRNAs, accession number, oncogene, target sites, description of genes and chromosome location.</p>
      </sec>
      <sec id="s2-s2-s2">
        <title>Front-end development</title>
        <p>The primary purpose of the ESOMIR interface is to provide intelligent interaction with a portal that gives the user a sense of acceptance. Ease and clarity are the foremost priorities to provide no-effort access to every group of users and enough technical assistance to do bioinformatics analysis with efficacy and effortlessness. We used Cascading Style Sheets (CSS), JavaScript, DataTables and Bootstrap to provide a modern look to this online portal.</p>
      </sec>
    </sec>
    <sec id="s2-s3">
      <title>Selection and validation of miRNAs as putative EC miRNAs</title>
      <p>In order to categorize potential miRNAs associated with EC, we performed prediction and analysis against all collected oncogenes using miRanda, RNA22v2 and DIANA-microT-CDS. To mine putative miRNAs, we established specific parameters for each algorithm. In miRanda, we set the analysis parameter to −15 kcal/mol energy level (EL) with a threshold of 120. The miRanda algorithm has standard settings for reasonably predicting potential target sites. The free energy of RNA molecules, which is involved in unfolding the interaction sites to allow the pairing of nucleotides between miRNAs and mRNAs, is an essential property that facilitates their interactions. Therefore, lower overall free energy means higher miRNA–mRNA complex stability, indicating a higher possibility of essential interactions.</p>
      <p>For RNA22v2, we selected entities with a folding energy of −12 with a <italic toggle="yes">P</italic>-value of 0.1 and more than three seeds. Additionally, we chose a threshold of 0.7 with a score of 90 using DIANA-microT-CDS, as this is the suggested threshold range for sensitive analysis for significant results. After all selection and analysis, we identified 2028 potential miRNAs and their associated target genes and pathways for EC. We excluded data entries that did not meet the inclusion criteria and all microRNA entities that did not meet the mentioned criteria. To assess the significance of ECOMIR among other existing database systems, we plot a comparison graph in <xref rid="F2" ref-type="fig">Figure 2A</xref>. We further validated the resulting miRNAs through miRWALK and TargetScan, where only experimentally validated connections were considered putative miRNAs.</p>
      <fig position="float" id="F2" fig-type="figure">
        <label>Figure 2.</label>
        <caption>
          <p>(<bold>A</bold>) Comparison of all available miRNA targets associated with EC in ESOMIR and other available databases. The figure shows that ESOMIR has the highest number of miRNAs included in contrast to the other available databases. (<bold>B</bold>) Comparison of all available mRNAs associated with EC in ESOMIR and other available databases.</p>
        </caption>
        <graphic xlink:href="baad063f2" position="float"/>
      </fig>
    </sec>
    <sec id="s2-s4">
      <title>Target-based network enrichment analysis via KEGG pathways</title>
      <p>EC is known to be regulated by different signaling pathways via microRNA, which have been shown to be significant players in the development of this disease (<xref rid="R55" ref-type="bibr">55–65</xref>). Using miRanda via KEGG, we identified some critical pathways in ESOMIR, including Wnt, NF-κB, TGFB, Apoptosis, Hippo, JAK-STAT and NOTCH, based on different ELs and a 120-threshold score. To ensure accuracy, we employed MirWalk and TargetScan for additional validation. In total, we identified 107 genes as miRNA targets across all signaling pathways in humans with EC. ESOMIR includes a higher number of genes as targets for EC-specific miRNAs compared to other cancer databases such as MirCosm, emiRiT (<xref rid="R66" ref-type="bibr">66</xref>), Mir2Disease, MirSystem, HMDD v2.0 (<xref rid="R43" ref-type="bibr">43</xref>) and miRCancer database (<xref rid="F2" ref-type="fig">Figure 2B</xref>).</p>
      <p>Among all signaling pathways, mTOR, apoptosis and NF-κB recorded the highest number of targeted mRNA–miRNA associated with EC, while NOTCH signaling had the least number of targets (<xref rid="F3" ref-type="fig">Figure 3</xref>). A single miRNA can target one or several genes, or several miRNAs can access a single target gene. Therefore, studying all signaling pathways associated with EC, either miRNA or mRNA, can lead to exciting discoveries. Further exploration of the interaction between miRNA–mRNA via signaling pathways could provide an in-depth understanding of possible miRNA–mRNA regulation. Considering the significant role of miRNAs in regulating mRNAs in disease development, we utilized data on miRNAs and their targets in each signaling pathway to recognize their interaction. To showcase the miRNA and target interaction, we proposed a binary matrix for each signaling pathway, with 1 indicating an mRNA targeted by miRNA and 0 indicating an mRNA not targeted. We then converted the miRNA–mRNA targets data frame into a matrix to extract error-free data using an open-source Bioconductor package of R.</p>
      <fig position="float" id="F3" fig-type="figure">
        <label>Figure 3.</label>
        <caption>
          <p>Signaling pathway targeted by selected putative miRNA associated with EC. The respective pathways along with their percentages are given and represented by different colors.</p>
        </caption>
        <graphic xlink:href="baad063f3" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec id="s3">
    <title>Results</title>
    <p>ESOMIR is a comprehensive database that extensively explores multiple paramount features related to EC information. The database contains a rich compilation of 125 unique genes and 877 miRNA targets implicated in EC. Accessible through a web-based portal, the database offers users access to various columns, each providing further details on the specific entity or entry under investigation. These columns include miRNA, accession, target site, EL, gene and associated information, chromosomal location and signaling pathway. Consequently, ESOMIR offers a holistic understanding of EC-related data.</p>
    <sec id="s3-s1">
      <title>Structure of the ESOMIR database modules</title>
      <p>We intentionally designed the homepage of ESOMIR to exhibit simplicity and comprehensiveness regarding EC information. Additionally, we presented abstract information about the project. The webpage comprises a header, footer, responsive side navigation bar and body. A Toggle button is incorporated to facilitate the users in showing or hiding the navigation bar. The side navigation bar serves as the primary menu, enabling users to access different options promptly. We provide five pages, including the homepage, search page, statistics page, help page and contact us page. To provide a visual representation of the home page, we illustrate <xref rid="F4" ref-type="fig">Figure 4</xref>.</p>
      <fig position="float" id="F4" fig-type="figure">
        <label>Figure 4.</label>
        <caption>
          <p>ESOMIR Homepage: a comprehensive miRNA database for EC. The home page shows the description of the database with different tabs that are included in the database. The Fuzzy Search Functionality implemented in ESOMIR is also given.</p>
        </caption>
        <graphic xlink:href="baad063f4" position="float"/>
      </fig>
    </sec>
    <sec id="s3-s2">
      <title>Fuzzy search</title>
      <p>On every page of ESOMIR, we provide a quick fuzzy term–based search to provide quick access to users. Users can give a minimum of three characters and get the results. Users can search in any context and retrieve any data record associated with EC. We implemented fuzzy search to ease the users who might need to search for the whole term or misspell it. This approach presents relevant results to the user. <xref rid="F4" ref-type="fig">Figure 4</xref> demonstrates the representation of fuzzy search.</p>
    </sec>
    <sec id="s3-s3">
      <title>Database gateways</title>
      <p>ESOMIR’s search page provides users with three methods to access and retrieve miRNA and their target information. The first approach involves an miRNA-based search, which offers users a selection of miRNA-related options, such as miRBase ID, accession or mature sequence. We make these options available through a drop-down menu and a search bar that users can utilize to filter or narrow their search based on specific data. The second option is gene-centric, enabling users to refine their search by selecting the gene symbol, Ensembl ID or Entrez ID. Enter the corresponding gene in the search box for specific gene data. The third and final method ESOMIR’s search page provides is interaction-network-based, which provides users with signaling pathways. The interaction-network-based method enables users to explore the signaling pathways associated with genes, miRNA and interaction by selecting pathways from a drop-down menu. Notable pathways include Wnt, NF-κB, TGFB, Apoptosis, Hippo, JAK-STAT and NOTCH. <xref rid="F5" ref-type="fig">Figure 5</xref> offers a comprehensive representation of ESOMIR’s search page.</p>
      <fig position="float" id="F5" fig-type="figure">
        <label>Figure 5.</label>
        <caption>
          <p>Demonstrative depiction of the Search page to access data using different modules. In the above figure from the database, it can be seen that the information can be retrieved through search by miRNA identifier search, search by target gene or miRNA or search for miRNA targeted pathway.</p>
        </caption>
        <graphic xlink:href="baad063f5" position="float"/>
      </fig>
    </sec>
    <sec id="s3-s4">
      <title>Upshot of data approachability</title>
      <p>The tabular format presents the search results, including columns for miRNA, mRNA and associated information. The first column displays the miRNA and its accession number, which serves as a redirecting link to <ext-link xlink:href="http://www.mirbase.org" ext-link-type="uri">www.mirbase.org</ext-link>. The table also shows the target sites, indicating the predicted target site of an miRNA gene, which can be 3ʹUTR, 5ʹUTR or exon. Additionally, there is a column that provides information on ELs in kcal/mol. The respective columns illustrate the associated pathways. Targeted gene information is available through a link that redirects to GenAtlas.</p>
      <p>Furthermore, the table provides accessibility links to <ext-link xlink:href="http://www.ensembl.org" ext-link-type="uri">www.ensembl.org</ext-link> and <ext-link xlink:href="http://www.biogps.org" ext-link-type="uri">www.biogps.org</ext-link>, allowing users to access the customizable layout through Ensembl ID and Entrez ID columns. The chromosome column provides the chromosomal location, with an accessible link to GeneCards, for users to obtain a broader vision of gene-centric information. The signaling pathways column maps the associated pathways of the specific miRNA, and users can also map the target gene onto the pathway in EC. The analysis includes vital pathways such as Wnt, NF-κB, TGFB, Apoptosis, Hippo, JAK-STAT and NOTCH. Users can access more detailed information about a specific pathway by being redirected to the KEGG pathway site. The resulting window provides pertinent information on crucial EC miRNAs and their well-recognized targets at various ELs. This information is deposited on the pathway information result page for users to access effortlessly. Target-based pathway information is available as an image file, which users can view in <xref rid="F6" ref-type="fig">Figure 6</xref>. The target pathway search module presents pathway results that differ from other modules. It presents information about miRNA–mRNA with 3ʹUTR, 5′UTR and exon in a network with associated nodes and connections. The target pathway search module presents pathway results that differ from other modules. It presents information about miRNA–mRNA with 3′UTR, 5ʹUTR and exon in a network with associated nodes and connections as shown in <xref rid="F7" ref-type="fig">Figure 7</xref>.</p>
      <fig position="float" id="F6" fig-type="figure">
        <label>Figure 6.</label>
        <caption>
          <p>An illustration of the ESOMIR result page presented in a tabular format. The results show the miRNA, accession ID, target site, EL and other information including the gene name and pathways.</p>
        </caption>
        <graphic xlink:href="baad063f6" position="float"/>
      </fig>
      <fig position="float" id="F7" fig-type="figure">
        <label>Figure 7.</label>
        <caption>
          <p>A depiction of the search results for the apoptosis signaling pathway, showcasing the target miRNA–mRNA network.</p>
        </caption>
        <graphic xlink:href="baad063f7" position="float"/>
      </fig>
    </sec>
    <sec id="s3-s5">
      <title>The importance and abundance of data represented in ESOMIR</title>
      <p>The abundance and importance of data in the ESOMIR database are by its large number of entries, which reflects the large number of studies that have been investigated to collect, validate and verify miRNA–target interactions associated with EC. The database currently includes &gt;2000 miRNA–target interactions curated from various sources, including experimental studies, computational predictions and literature mining. The density of data can be viewed in <xref rid="F8" ref-type="fig">Figure 8</xref>.</p>
      <fig position="float" id="F8" fig-type="figure">
        <label>Figure 8.</label>
        <caption>
          <p>An illustration of &gt;2000 mRNA–miRNA interactions that are exclusively linked to EC in the ESOMIR database.</p>
        </caption>
        <graphic xlink:href="baad063f8" position="float"/>
      </fig>
      <p>The diverse information available in the ESOMIR database, including miRNA–target interactions along with their associated signaling pathways, is shown in <xref rid="F9" ref-type="fig">Figure 9</xref>. This vast collection of information can be used to investigate the regulatory networks of miRNAs and their target genes in various biological processes, such as development, differentiation and disease. By utilizing the ESOMIR database, researchers can gain insight into the complex mechanisms underlying miRNA-mediated gene regulation and its role in disease pathogenesis, which could lead to the identification of potential therapeutic targets.</p>
      <fig position="float" id="F9" fig-type="figure">
        <label>Figure 9.</label>
        <caption>
          <p>A depiction of the miRNA–target interactions, along with their corresponding signaling pathways.</p>
        </caption>
        <graphic xlink:href="baad063f9" position="float"/>
      </fig>
      <p>Furthermore, we selected the key gene and key miRNA on the basis of binding site, rank score, number of targets and ELs. We illustrated the top 10% targeted/selected genes and miRNAs associated with EC. Few listed miRNAs are hsa-miR-6807-3p, hsa-miR-133a-3p, hsa-miR-6809-3p, hsa-miR-6867-5p, hsa-miR-6511a-5p, hsa-miR-92a-3p, hsa-miR-6738-3p, hsa-miR-7854-3p, hsa-miR-145-5p, hsa-miR-181b-5p, hsa-miR-183-5p, hsa-miR-544b, hsa-miR-6512-3p, hsa-miR-6758-5p, hsa-miR-6847-5p, hsa-miR-6893-5p, hsa-miR-106b-5p, hsa-miR-183-3p, hsa-miR-320b, hsa-miR-320c, hsa-miR-34a-5p, hsa-miR-107, hsa-miR-16-1-3p, hsa-miR-181d-5p, hsa-miR-200a-3p, hsa-miR-485-5p, hsa-miR-107, hsa-miR-124-3p, hsa-miR-200b-3p, hsa-miR-21-3p, hsa-miR-30a-3p, hsa-miR-92b-3p and hsa-miR-93-5p, and genes are BRCA1, CTNNA1, DCC, FGF2, HMOX1, LZTS1, MXI1, PTEN, RNF6 and TGFBR2. We illustrated the associations using a network as shown in <xref rid="F10" ref-type="fig">Figure 10C</xref>. However, top 10% gene with highest score can be seen in <xref rid="F10" ref-type="fig">Figure 10A</xref> and top 10% miRNA can be seen in <xref rid="F10" ref-type="fig">Figure 10B</xref>.</p>
      <fig position="float" id="F10" fig-type="figure">
        <label>Figure 10.</label>
        <caption>
          <p>An illustration of top key mRNA and miRNA targets associated with EC. (<bold>A</bold>) The top 10% identified genes associated with EC. (<bold>B</bold>) The top 10% identified miRNAs associated with EC. (<bold>C</bold>) A network that visualizes the top connections and associations between mRNA and miRNAs, highlighting the most significant interactions among them.</p>
        </caption>
        <graphic xlink:href="baad063f10" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec id="s4">
    <title>Discussion</title>
    <p>Biological data have become a critical resource for studying complex diseases, with numerous databases available to target specific diseases and associated data. However, while miRNAs-based databases and their targets are essential, only some compile comprehensive knowledge about specific diseases and their targets. Currently, no available database exclusively provides information on the association of miRNAs with EC. To address this, we have developed ESOMIR, a dynamic and user-friendly database that provides comprehensive information on predicted and experimentally validated miRNAs with their putative targets. This database is anticipated to aid in the discovery of potential biomarkers for EC that possess diagnostic and therapeutic characteristics. Compared to other databases such as MicroCosm, miR2Disease, eMirit, TargetScan, HMDD v2.0 and miRCancer, ESOMIR contains the highest number of EC-specific miRNAs, with 877 humans (<xref rid="F2" ref-type="fig">Figure 2A</xref>). This research also introduces novel miRNAs with their target information in different pathways. The ESOMIR database has a user-friendly web interface that enables the query of miRNAs, target mRNAs and their interaction network. Additionally, it provides target-ontology information for all genes in oncogenic pathways, making it a widespread platform for studying miRNA and its alleged role in the development and progression of EC. The identification and functional prediction of miRNA targets is essential in assessing the role of miRNAs in regulating or deregulating common genes and pathways that contribute to cancer development (<xref rid="R67" ref-type="bibr">67</xref>). Despite the continuous evolution of miRNA target prediction algorithms, effective prediction of miRNA targets in animals remains more challenging than in plants (<xref rid="R68" ref-type="bibr">68</xref>). miRNAs regulate target genes by binding to their 3ʹUTR, 5ʹUTR or coding regions through the seed region (5ʹ ends of miRNA), making it a more difficult task for target prediction tools because of incomplete base pairing at the complementary site (<xref rid="R69" ref-type="bibr">69</xref>). To minimize false positives, we employed a well-known target prediction algorithm, miRanda, RNA22v2 and DIANA-microR-CDS at different ELs, with validation by mirWalk and TargetScan. Targets predicted at the lowest EL 30 represent a strong pairing of miRNA to its target, whereas EL 15 is a more relaxed criterion for finding novel miRNA targets. This approach can help researchers narrow down and screen the most promising putative miRNA targets in acute lymphoblastic leukemia for validation. We found that the ESOMIR database contains 123 miRNA targets for humans, representing the highest number of predicted putative targets for EC miRNAs compared to any other available database (<xref rid="F2" ref-type="fig">Figure 2B</xref>). Down-regulation of a wide range of oncogenes through miRNAs involved in different signaling pathways can maintain the healthy background of normal cells. Therefore, classifying EC miRNA targets based on different signaling pathways and interpreting miRNA–mRNA interaction networks at 3ʹUTR, 5ʹUTR and exon regions of target genes could provide detailed information on the role of miRNAs in EC initiation and progression. Several studies demonstrate the interaction between miRNA and signaling pathways during all procedures/hallmarks in EC. For instance, Li <italic toggle="yes">et al.</italic> reported cross-interaction between miRNA and NOTCH signaling in EC, specifically in ESCC (<xref rid="R70" ref-type="bibr">70</xref>). Moreover, Gao <italic toggle="yes">et al.</italic> demonstrated that the overexpression of miR-31 is an oncogene in ESCC, repressing the expression of LATS2 by the Hippo pathway and activating epithelial–mesenchymal transition (<xref rid="R71" ref-type="bibr">71</xref>).</p>
    <p>According to the ESOMIR database, the interaction between miRNA–mRNA networks in different signaling pathways is crucial in facilitating cross talks, for example, miR-34a-5p inhibits proliferation, migration, invasion and epithelial–mesenchymal transition in ESCC by targeting LEF1 and inactivating the Hippo–YAP1/TAZ Signaling Pathway (<xref rid="R72" ref-type="bibr">72</xref>). miRNA-373 also promotes the development of ESCC by targeting LATS2 and OXR1. Furthermore, miRNA-21 promotes cell proliferation, migration and resistance to apoptosis in EC through the PTEN/PI3K/AKT signaling pathway (<xref rid="R58" ref-type="bibr">58</xref>, <xref rid="R73" ref-type="bibr">73</xref>). The mTOR pathway and its interaction networks are identified as potential therapeutic targets in the treatment of EC (<xref rid="R59" ref-type="bibr">59</xref>). Researchers have identified the NF-κB signaling pathway as a transcriptional activator for a potential molecular marker for predicting and improving treatment efficacy in EC (<xref rid="R74" ref-type="bibr">74–76</xref>). The researchers have defined the roles of Wnt/β-catenin signaling pathway–related miRNAs in EC (<xref rid="R64" ref-type="bibr">64</xref>). They have found that down-regulation of miR-30a-3p/5p by activating the Wnt signaling pathway promotes cell proliferation in ESCC (<xref rid="R77" ref-type="bibr">77</xref>).</p>
    <p>Various miRNAs are considered tumor suppressors or oncogenes in EC, including miR-10ab, miR-133ab, miR-145, miR-205, miR-99b, miR-199a-3p, miR-199a-5p, miR-126, miR-16-2, miR-15b, miR-143, miR-233, miR-486-5p and let-7a, as well as PDCD4, PTEN, ZEB1, Lzts, FGF2, DCC, MXI1, RNF6 and TGFB (<xref rid="R78" ref-type="bibr">78–87</xref>). The ESOMIR database provides information about these critical biomarkers and their associated targets. The functional annotation of miRNA targets at different cellular and molecular levels is essential for a systematic ontology of miRNAs. The ESOMIR database assigns ontology to targets of miRNAs and their association with biological processes at the cellular and molecular levels. Exploring relations between miRNA target genes and diseases could simplify our understanding of the pathogenesis of cancer and its progression. This information could help further understand the role of the miRNA cluster in regulating diverse pathways, leading to the development of novel therapeutic regimens for EC.</p>
  </sec>
  <sec id="s5">
    <title>Conclusion</title>
    <p>The ESOMIR database is a valuable resource for researchers and clinicians interested in studying miRNA–target interactions associated with EC. With &gt;2000 meticulously curated miRNA–target interactions, this database provides a wealth of information on the regulatory networks of miRNAs and their target genes in various biological processes. The database uses analysis and prediction methods, including experimentally endorsed miRNA(s) information. ESOMIR is a user-friendly interface that allows easy access to EC-associated data by searching for miRNAs, target genes, sequences, chromosomal positions and associated signaling pathways. The search modules are designed to provide specific data access to users based on their requirements. Additionally, the database provides information about network interactions, signaling pathways and region information of chromosomes associated with the 3ʹUTR or 5ʹUTR and exon sites. Overall, the ESOMIR database is a promising platform for identifying potential therapeutic targets and developing personalized cancer treatments. In addition to the current features and information in the ESOMIR database, future updates could include additional data on miRNA–target interactions associated with other types of cancers or diseases. These updates would further expand the database’s usefulness and make it a more comprehensive resource for researchers and clinicians. Additionally, incorporating machine learning algorithms could help to identify novel miRNA–target interactions and further enhance the predictive power of the database.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>baad063_Supp</label>
      <media xlink:href="baad063_supp.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>Authors are thankful to the Researchers Supporting Project number (RSP2023R491), King Saud University, Riyadh, Saudi Arabia.</p>
  </ack>
  <sec id="s6">
    <title>Supplementary material</title>
    <p><xref rid="sup1" ref-type="supplementary-material">Supplementary material</xref> is available at <italic toggle="yes">Database</italic> online.</p>
  </sec>
  <sec sec-type="data-availability" id="s7">
    <title>Data availability</title>
    <p>The data used to develop the database is attached as a supplementary file.</p>
  </sec>
  <sec id="s8">
    <title>Funding</title>
    <p>National Key R&amp;D Program of China (2021YFA0911500); Shanghai Pujiang Program (21PJ1405100); National Science Foundation of China (32070662, 61832019, 32030063) to D.-Q.W.; Science and Technology Commission of Shanghai Municipality (19430750600); SJTU JiRLMDS Joint Research Fund and Joint Research Funds for Medical and Engineering and Scientific Research at Shanghai Jiao Tong University (YG2021ZD02).</p>
  </sec>
  <sec sec-type="COI-statement" id="s9">
    <title>Conflict of interest</title>
    <p>The authors declare no conflict of interest.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="R1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sung</surname><given-names>H.</given-names></string-name>, <string-name><surname>Ferlay</surname><given-names>J.</given-names></string-name>, <string-name><surname>Siegel</surname><given-names>R.L.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>. <source><italic toggle="yes">CA Cancer J. Clin.</italic></source>, <volume>71</volume>, <fpage>209</fpage>–<lpage>249</lpage>.<pub-id pub-id-type="pmid">33538338</pub-id></mixed-citation>
    </ref>
    <ref id="R2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bandla</surname><given-names>S.</given-names></string-name>, <string-name><surname>Pennathur</surname><given-names>A.</given-names></string-name>, <string-name><surname>Luketich</surname><given-names>J.D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma</article-title>. <source><italic toggle="yes">Ann. Thorac. Surg.</italic></source>, <volume>93</volume>, <fpage>1101</fpage>–<lpage>1106</lpage>.<pub-id pub-id-type="pmid">22450065</pub-id></mixed-citation>
    </ref>
    <ref id="R3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Navab</surname><given-names>F.</given-names></string-name>, <string-name><surname>Nathanson</surname><given-names>B.H.</given-names></string-name> and <string-name><surname>Desilets</surname><given-names>D.J.</given-names></string-name></person-group> (<year>2015</year>) <article-title>The impact of lifestyle on Barrett’s esophagus: a precursor to esophageal adenocarcinoma</article-title>. <source><italic toggle="yes">Cancer Epidemiol.</italic></source>, <volume>39</volume>, <fpage>885</fpage>–<lpage>891</lpage>.<pub-id pub-id-type="pmid">26519660</pub-id></mixed-citation>
    </ref>
    <ref id="R4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Network</surname><given-names>C.G.A.R.</given-names></string-name></person-group><etal>et al.</etal> (<year>2017</year>) <article-title>Integrated genomic characterization of oesophageal carcinoma</article-title>. <source><italic toggle="yes">Nature</italic></source>, <volume>541</volume>, <fpage>169</fpage>–<lpage>175</lpage>.<pub-id pub-id-type="pmid">28052061</pub-id></mixed-citation>
    </ref>
    <ref id="R5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Arnal</surname><given-names>M.J.D.</given-names></string-name>, <string-name><surname>Arenas</surname><given-names>Á.F.</given-names></string-name> and <string-name><surname>Arbeloa</surname><given-names>Á.L.</given-names></string-name></person-group> (<year>2015</year>) <article-title>Esophageal cancer: risk factors, screening and endoscopic treatment in western and eastern countries</article-title>. <source><italic toggle="yes">World J. Gastroenterol.</italic></source>, <volume>21</volume>, <fpage>7933</fpage>–<lpage>7943</lpage>.<pub-id pub-id-type="pmid">26185366</pub-id></mixed-citation>
    </ref>
    <ref id="R6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Griffiths-Jones</surname><given-names>S.</given-names></string-name></person-group> (<year>2007</year>) <article-title>Annotating noncoding RNA genes</article-title>. <source><italic toggle="yes">Annu. Rev. Genomics Hum. Genet.</italic></source><volume>8</volume>, <fpage>279</fpage>–<lpage>298</lpage>.<pub-id pub-id-type="pmid">17506659</pub-id></mixed-citation>
    </ref>
    <ref id="R7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bartel</surname><given-names>D.P.</given-names></string-name></person-group> (<year>2009</year>) <article-title>MicroRNAs: target recognition and regulatory functions</article-title>. <source><italic toggle="yes">Cell</italic></source>, <volume>136</volume>, <fpage>215</fpage>–<lpage>233</lpage>.<pub-id pub-id-type="pmid">19167326</pub-id></mixed-citation>
    </ref>
    <ref id="R8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>B.</given-names></string-name>, <string-name><surname>Pan</surname><given-names>X.</given-names></string-name>, <string-name><surname>Cobb</surname><given-names>G.P.</given-names></string-name></person-group><etal>et al.</etal> (<year>2007</year>) <article-title>MicroRNAs as oncogenes and tumor suppressors</article-title>. <source><italic toggle="yes">Dev. Biol.</italic></source>, <volume>302</volume>, <fpage>1</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">16989803</pub-id></mixed-citation>
    </ref>
    <ref id="R9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lynam-Lennon</surname><given-names>N.</given-names></string-name>, <string-name><surname>Maher</surname><given-names>S.G.</given-names></string-name> and <string-name><surname>Reynolds</surname><given-names>J.V.</given-names></string-name></person-group> (<year>2009</year>) <article-title>The roles of microRNA in cancer and apoptosis</article-title>. <source><italic toggle="yes">Biol. Rev.</italic></source>, <volume>84</volume>, <fpage>55</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">19046400</pub-id></mixed-citation>
    </ref>
    <ref id="R10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tutar</surname><given-names>L.</given-names></string-name>, <string-name><surname>Tutar</surname><given-names>E.</given-names></string-name> and <string-name><surname>Tutar</surname><given-names>Y.</given-names></string-name></person-group> (<year>2014</year>) <article-title>MicroRNAs and cancer; an overview</article-title>. <source><italic toggle="yes">Curr. Pharm. Biotechnol.</italic></source>, <volume>15</volume>, <fpage>430</fpage>–<lpage>437</lpage>.<pub-id pub-id-type="pmid">24846068</pub-id></mixed-citation>
    </ref>
    <ref id="R11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Calin</surname><given-names>G.A.</given-names></string-name>, <string-name><surname>Sevignani</surname><given-names>C.</given-names></string-name>, <string-name><surname>Dumitru</surname><given-names>C.D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2004</year>) <article-title>Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers</article-title>. <source><italic toggle="yes">Proc. Natl. Acad. Sci. U.S.A.</italic></source>, <volume>101</volume>, <fpage>2999</fpage>–<lpage>3004</lpage>.<pub-id pub-id-type="pmid">14973191</pub-id></mixed-citation>
    </ref>
    <ref id="R12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abbas</surname><given-names>G.</given-names></string-name> and <string-name><surname>Krasna</surname><given-names>M.</given-names></string-name></person-group> (<year>2017</year>) <article-title>Overview of esophageal cancer</article-title>. <source><italic toggle="yes">Ann. Cardiothorac. Surg.</italic></source>, <volume>6</volume>, <fpage>131</fpage>–<lpage>136</lpage>.<pub-id pub-id-type="pmid">28447001</pub-id></mixed-citation>
    </ref>
    <ref id="R13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>X.</given-names></string-name>, <string-name><surname>Duan</surname><given-names>N.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>C.</given-names></string-name></person-group><etal>et al.</etal> (<year>2016</year>) <article-title>Survivin and tumorigenesis: molecular mechanisms and therapeutic strategies</article-title>. <source><italic toggle="yes">J. Cancer</italic></source>, <volume>7</volume>, <fpage>314</fpage>–<lpage>323</lpage>.<pub-id pub-id-type="pmid">26918045</pub-id></mixed-citation>
    </ref>
    <ref id="R14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sethi</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ali</surname><given-names>S.</given-names></string-name>, <string-name><surname>Philip</surname><given-names>P.A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2013</year>) <article-title>Clinical advances in molecular biomarkers for cancer diagnosis and therapy</article-title>. <source><italic toggle="yes">Int. J. Mol. Sci.</italic></source>, <volume>14</volume>, <fpage>14771</fpage>–<lpage>14784</lpage>.<pub-id pub-id-type="pmid">23863689</pub-id></mixed-citation>
    </ref>
    <ref id="R15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hassanein</surname><given-names>M.</given-names></string-name>, <string-name><surname>Callison</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Callaway-Lane</surname><given-names>C.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>The state of molecular biomarkers for the early detection of lung cancer</article-title>. <source><italic toggle="yes">Cancer Prevent. Res.</italic></source>, <volume>5</volume>, <fpage>992</fpage>–<lpage>1006</lpage>.</mixed-citation>
    </ref>
    <ref id="R16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tsuchiya</surname><given-names>N.</given-names></string-name>, <string-name><surname>Sawada</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Endo</surname><given-names>I.</given-names></string-name></person-group><etal>et al.</etal> (<year>2015</year>) <article-title>Biomarkers for the early diagnosis of hepatocellular carcinoma</article-title>. <source><italic toggle="yes">World J. Gastroenterol.</italic></source>, <volume>21</volume>, <fpage>10573</fpage>–<lpage>10583</lpage>.<pub-id pub-id-type="pmid">26457017</pub-id></mixed-citation>
    </ref>
    <ref id="R17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nangraj</surname><given-names>A.S.</given-names></string-name>, <string-name><surname>Selvaraj</surname><given-names>G.</given-names></string-name>, <string-name><surname>Kaliamurthi</surname><given-names>S.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>Integrated PPI- and WGCNA-retrieval of hub gene signatures shared between Barrett’s esophagus and esophageal adenocarcinoma</article-title>. <source><italic toggle="yes">Front. Pharmacol.</italic></source>, <volume>11</volume>, <fpage>1</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">32116689</pub-id></mixed-citation>
    </ref>
    <ref id="R18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Wei</surname><given-names>Y.K.</given-names></string-name>, <string-name><surname>Kaliamurthi</surname><given-names>S.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>Circulating mir-1246 targeting UBE2C, TNNI3, TRAIP, UCHL1 genes and key pathways as a potential biomarker for lung adenocarcinoma: integrated biological network analysis</article-title>. <source><italic toggle="yes">J. Pers. Med.</italic></source>, <volume>10</volume>, <fpage>1</fpage>–<lpage>20</lpage>.</mixed-citation>
    </ref>
    <ref id="R19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Yin</surname><given-names>H.</given-names></string-name>, <string-name><surname>Shi</surname><given-names>L.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>A novel microRNA signature for pathological grading in lung adenocarcinoma based on TCGA and GEO data</article-title>. <source><italic toggle="yes">Int. J. Mol. Med.</italic></source>, <volume>45</volume>, <fpage>1397</fpage>–<lpage>1408</lpage>.<pub-id pub-id-type="pmid">32323746</pub-id></mixed-citation>
    </ref>
    <ref id="R20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Kong</surname><given-names>D.</given-names></string-name>, <string-name><surname>Cui</surname><given-names>Q.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>Prognostic genes of breast cancer identified by gene co-expression network analysis</article-title>. <source><italic toggle="yes">Front. Oncol.</italic></source>, <volume>8</volume>, <page-range>374</page-range>.</mixed-citation>
    </ref>
    <ref id="R21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>He</surname><given-names>S.</given-names></string-name>, <string-name><surname>Shi</surname><given-names>J.</given-names></string-name>, <string-name><surname>Mao</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2019</year>) <article-title>The expression of mir-375 in prostate cancer: a study based on GEO, TCGA data and bioinformatics analysis</article-title>. <source><italic toggle="yes">Pathol. Res. Pract.</italic></source>, <volume>215</volume>, <fpage>1</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">30396757</pub-id></mixed-citation>
    </ref>
    <ref id="R22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rajewsky</surname><given-names>N.</given-names></string-name> and <string-name><surname>Socci</surname><given-names>N.D.</given-names></string-name></person-group> (<year>2004</year>) <article-title>Computational identification of microRNA targets</article-title>. <source><italic toggle="yes">Genome Biol.</italic></source>, <volume>5</volume>, <fpage>1</fpage>–<lpage>35</lpage>.</mixed-citation>
    </ref>
    <ref id="R23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Feber</surname><given-names>A.</given-names></string-name>, <string-name><surname>Xi</surname><given-names>L.</given-names></string-name>, <string-name><surname>Luketich</surname><given-names>J.D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2008</year>) <article-title>MicroRNA expression profiles of esophageal cancer</article-title>. <source><italic toggle="yes">J. Thorac. Cardiovasc. Surg.</italic></source>, <volume>135</volume>, <fpage>255</fpage>–<lpage>260</lpage>.<pub-id pub-id-type="pmid">18242245</pub-id></mixed-citation>
    </ref>
    <ref id="R24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>He</surname><given-names>B.</given-names></string-name>, <string-name><surname>Yin</surname><given-names>B.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>B.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>MicroRNAs in esophageal cancer</article-title>. <source><italic toggle="yes">Mol. Med. Rep.</italic></source>, <volume>6</volume>, <fpage>459</fpage>–<lpage>465</lpage>.<pub-id pub-id-type="pmid">22751839</pub-id></mixed-citation>
    </ref>
    <ref id="R25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harada</surname><given-names>K.</given-names></string-name>, <string-name><surname>Baba</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ishimoto</surname><given-names>T.</given-names></string-name></person-group><etal>et al.</etal> (<year>2016</year>) <article-title>The role of microRNA in esophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">J. Gastroenterol.</italic></source>, <volume>51</volume>, <fpage>520</fpage>–<lpage>530</lpage>.<pub-id pub-id-type="pmid">26794004</pub-id></mixed-citation>
    </ref>
    <ref id="R26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gao</surname><given-names>R.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Q.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>MicroRNA-105 plays an independent prognostic role in esophageal cancer and acts as an oncogene</article-title>. <source><italic toggle="yes">Cancer Biomark.</italic></source>, <volume>27</volume>, <fpage>173</fpage>–<lpage>180</lpage>.<pub-id pub-id-type="pmid">31796663</pub-id></mixed-citation>
    </ref>
    <ref id="R27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Garman</surname><given-names>K.S.</given-names></string-name>, <string-name><surname>Owzar</surname><given-names>K.</given-names></string-name>, <string-name><surname>Hauser</surname><given-names>E.R.</given-names></string-name></person-group><etal>et al.</etal> (<year>2013</year>) <article-title>MicroRNA expression differentiates squamous epithelium from Barrett’s esophagus and esophageal cancer</article-title>. <source><italic toggle="yes">Dig. Dis. Sci.</italic></source>, <volume>58</volume>, <fpage>3178</fpage>–<lpage>3188</lpage>.<pub-id pub-id-type="pmid">23925817</pub-id></mixed-citation>
    </ref>
    <ref id="R28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Griffiths-Jones</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Grocock</surname><given-names>S.</given-names></string-name>, <string-name><surname>Van Dongen</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2006</year>) <article-title>Enright, miRBase: microRNA sequences, targets and gene nomenclature</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>34</volume>, <fpage>D140</fpage>–<lpage>D144</lpage>.<pub-id pub-id-type="pmid">16381832</pub-id></mixed-citation>
    </ref>
    <ref id="R29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Georgakilas</surname><given-names>G.</given-names></string-name>, <string-name><surname>Vlachos</surname><given-names>I.S.</given-names></string-name>, <string-name><surname>Zagganas</surname><given-names>K.</given-names></string-name></person-group><etal>et al.</etal> (<year>2016</year>) <article-title>DIANA-miRGen v3.0: accurate characterization of microRNA promoters and their regulators</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>44</volume>, <fpage>D190</fpage>–<lpage>D195</lpage>.<pub-id pub-id-type="pmid">26586797</pub-id></mixed-citation>
    </ref>
    <ref id="R30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cho</surname><given-names>S.</given-names></string-name>, <string-name><surname>Jang</surname><given-names>I.</given-names></string-name>, <string-name><surname>Jun</surname><given-names>Y.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>Mirgator v3.0: a microRNA portal for deep sequencing, expression profiling and mRNA targeting</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>41</volume>, <fpage>D252</fpage>–<lpage>D257</lpage>.<pub-id pub-id-type="pmid">23193297</pub-id></mixed-citation>
    </ref>
    <ref id="R31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sticht</surname><given-names>C.</given-names></string-name>, <string-name><surname>De La Torre</surname><given-names>C.</given-names></string-name>, <string-name><surname>Parveen</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>miRWalk: an online resource for prediction of microRNA binding sites</article-title>. <source><italic toggle="yes">PLoS One</italic></source>, <volume>13</volume>, <fpage>1</fpage>–<lpage>6</lpage>.</mixed-citation>
    </ref>
    <ref id="R32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>H.Y.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>Y.C.D.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>miRTarBase 2020: updates to the experimentally validated microRNA–target interaction database</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>48</volume>, <fpage>D148</fpage>–<lpage>D154</lpage>.<pub-id pub-id-type="pmid">31647101</pub-id></mixed-citation>
    </ref>
    <ref id="R33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hsu</surname><given-names>P.W.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>H.D.</given-names></string-name>, <string-name><surname>Hsu</surname><given-names>S.D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2006</year>) <article-title>miRNAMap: genomic maps of microRNA genes and their target genes in mammalian genomes</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>1</volume>, <fpage>D135</fpage>–<lpage>D139</lpage>.</mixed-citation>
    </ref>
    <ref id="R34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xiao</surname><given-names>F.</given-names></string-name>, <string-name><surname>Zuo</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Cai</surname><given-names>G.</given-names></string-name></person-group><etal>et al.</etal> (<year>2009</year>) <article-title>miRecords: an integrated resource for microRNA–target interactions</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>37</volume>, <fpage>D105</fpage>–<lpage>D110</lpage>.<pub-id pub-id-type="pmid">18996891</pub-id></mixed-citation>
    </ref>
    <ref id="R35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Agarwal</surname><given-names>V.</given-names></string-name>, <string-name><surname>Bell</surname><given-names>G.W.</given-names></string-name>, <string-name><surname>Nam</surname><given-names>J.W.</given-names></string-name></person-group><etal>et al.</etal> (<year>2015</year>) <article-title>Predicting effective microRNA target sites in mammalian mRNAs</article-title>. <source><italic toggle="yes">eLife</italic></source>, <volume>4</volume>, <page-range>e05005</page-range>.</mixed-citation>
    </ref>
    <ref id="R36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wong</surname><given-names>N.</given-names></string-name> and <string-name><surname>Wang</surname><given-names>X.</given-names></string-name></person-group> (<year>2015</year>) <article-title>miRDB: an online resource for microRNA target prediction and functional annotations</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>43</volume>, <fpage>D146</fpage>–<lpage>D152</lpage>.<pub-id pub-id-type="pmid">25378301</pub-id></mixed-citation>
    </ref>
    <ref id="R37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Krek</surname><given-names>A.</given-names></string-name>, <string-name><surname>Grün</surname><given-names>D.</given-names></string-name>, <string-name><surname>Poy</surname><given-names>M.N.</given-names></string-name></person-group><etal>et al.</etal> (<year>2005</year>) <article-title>Combinatorial microRNA target predictions</article-title>. <source><italic toggle="yes">Nat. Genet.</italic></source>, <volume>37</volume>, <fpage>495</fpage>–<lpage>500</lpage>.<pub-id pub-id-type="pmid">15806104</pub-id></mixed-citation>
    </ref>
    <ref id="R38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Quillet</surname><given-names>A.</given-names></string-name>, <string-name><surname>Saad</surname><given-names>C.</given-names></string-name>, <string-name><surname>Ferry</surname><given-names>G.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>Improving bioinformatics prediction of microRNA targets by ranks aggregation</article-title>. <source><italic toggle="yes">Front. Genet.</italic></source>, <volume>10</volume>, <fpage>1</fpage>–<lpage>14</lpage>.</mixed-citation>
    </ref>
    <ref id="R39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Khurana</surname><given-names>R.</given-names></string-name>, <string-name><surname>Verma</surname><given-names>V.K.</given-names></string-name>, <string-name><surname>Rawoof</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>OncomiRdbB: a comprehensive database of microRNAs and their targets in breast cancer</article-title>. <source><italic toggle="yes">BMC Bioinform.</italic></source>, <volume>15</volume>, <fpage>1</fpage>–<lpage>12</lpage>.</mixed-citation>
    </ref>
    <ref id="R40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xie</surname><given-names>B.</given-names></string-name>, <string-name><surname>Ding</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Han</surname><given-names>H.</given-names></string-name></person-group><etal>et al.</etal> (<year>2013</year>) <article-title>miRCancer: a microRNA–cancer association database constructed by text mining on literature</article-title>. <source><italic toggle="yes">Bioinformatics</italic></source>, <volume>29</volume>, <fpage>638</fpage>–<lpage>644</lpage>.<pub-id pub-id-type="pmid">23325619</pub-id></mixed-citation>
    </ref>
    <ref id="R41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tan</surname><given-names>H.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>P.</given-names></string-name>, <string-name><surname>Sun</surname><given-names>P.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>miRactDB characterizes miRNA–gene relation switch between normal and cancer tissues across pan-cancer</article-title>. <source><italic toggle="yes">Brief. Bioinform.</italic></source>, <volume>22</volume>, <page-range>bbaa089</page-range>.</mixed-citation>
    </ref>
    <ref id="R42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ruepp</surname><given-names>A.</given-names></string-name>, <string-name><surname>Kowarsch</surname><given-names>A.</given-names></string-name>, <string-name><surname>Schmidl</surname><given-names>D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2010</year>) <article-title>PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes</article-title>. <source><italic toggle="yes">Genome Biol.</italic></source>, <volume>11</volume>, <fpage>1</fpage>–<lpage>11</lpage>.</mixed-citation>
    </ref>
    <ref id="R43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Qiu</surname><given-names>C.</given-names></string-name>, <string-name><surname>Tu</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>HMDD v2.0: a database for experimentally supported human microRNA and disease associations</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>42</volume>, <fpage>D1070</fpage>–<lpage>D1074</lpage>.<pub-id pub-id-type="pmid">24194601</pub-id></mixed-citation>
    </ref>
    <ref id="R44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sarver</surname><given-names>A.L.</given-names></string-name>, <string-name><surname>Phalak</surname><given-names>R.</given-names></string-name>, <string-name><surname>Thayanithy</surname><given-names>V.</given-names></string-name></person-group><etal>et al.</etal> (<year>2010</year>) <article-title>S-MED: sarcoma microRNA expression database</article-title>. <source><italic toggle="yes">Lab. Invest.</italic></source>, <volume>90</volume>, <fpage>753</fpage>–<lpage>761</lpage>.<pub-id pub-id-type="pmid">20212452</pub-id></mixed-citation>
    </ref>
    <ref id="R45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hao</surname><given-names>Y.</given-names></string-name></person-group><etal>et al.</etal> (<year>2009</year>) <article-title>mir2disease: a manually curated database for microRNA deregulation in human disease</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>37</volume>, <fpage>D98</fpage>–<lpage>D104</lpage>.<pub-id pub-id-type="pmid">18927107</pub-id></mixed-citation>
    </ref>
    <ref id="R46">
      <label>46.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname><given-names>T.P.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>C.Y.</given-names></string-name>, <string-name><surname>Tsai</surname><given-names>M.H.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>miRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets</article-title>. <source><italic toggle="yes">PLoS One</italic></source>, <volume>7</volume>, <fpage>1</fpage>–<lpage>14</lpage>.</mixed-citation>
    </ref>
    <ref id="R47">
      <label>47.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Forbes</surname><given-names>S.</given-names></string-name>, <string-name><surname>Clements</surname><given-names>J.</given-names></string-name>, <string-name><surname>Dawson</surname><given-names>E.</given-names></string-name></person-group><etal>et al.</etal> (<year>2006</year>) <article-title>COSMIC 2005</article-title>. <source><italic toggle="yes">Br. J. Cancer</italic></source>, <volume>94</volume>, <fpage>318</fpage>–<lpage>322</lpage>.<pub-id pub-id-type="pmid">16421597</pub-id></mixed-citation>
    </ref>
    <ref id="R48">
      <label>48.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kanehisa</surname><given-names>M.</given-names></string-name> and <string-name><surname>Goto</surname><given-names>S.</given-names></string-name></person-group> (<year>2000</year>) <article-title>KEGG: Kyoto Encyclopedia of Genes and Genomes</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>28</volume>, <fpage>27</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">10592173</pub-id></mixed-citation>
    </ref>
    <ref id="R49">
      <label>49.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Essack</surname><given-names>M.</given-names></string-name>, <string-name><surname>Radovanovic</surname><given-names>A.</given-names></string-name>, <string-name><surname>Schaefer</surname><given-names>U.</given-names></string-name></person-group><etal>et al.</etal> (<year>2009</year>) <article-title>DDEC: Dragon database of genes implicated in esophageal cancer</article-title>. <source><italic toggle="yes">BMC Cancer</italic></source>, <volume>9</volume>, <fpage>1</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">19118499</pub-id></mixed-citation>
    </ref>
    <ref id="R50">
      <label>50.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kato</surname><given-names>K.</given-names></string-name>, <string-name><surname>Yamashita</surname><given-names>R.</given-names></string-name>, <string-name><surname>Matoba</surname><given-names>R.</given-names></string-name></person-group><etal>et al.</etal> (<year>2005</year>) <article-title>Cancer gene expression database (CGED): a database for gene expression profiling with accompanying clinical information of human cancer tissues</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>33</volume>, <fpage>D533</fpage>–<lpage>D536</lpage>.<pub-id pub-id-type="pmid">15608255</pub-id></mixed-citation>
    </ref>
    <ref id="R51">
      <label>51.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Piñero</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ramírez-Anguita</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Saüch-Pitarch</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>The DisGeNET knowledge platform for disease genomics: 2019 update</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>48</volume>, <fpage>D845</fpage>–<lpage>D855</lpage>.<pub-id pub-id-type="pmid">31680165</pub-id></mixed-citation>
    </ref>
    <ref id="R52">
      <label>52.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kinsella</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Kähäri</surname><given-names>A.</given-names></string-name>, <string-name><surname>Haider</surname><given-names>S.</given-names></string-name></person-group><etal>et al.</etal> (<year>2011</year>) <article-title>Ensembl BioMarts: a hub for data retrieval across taxonomic space</article-title>. <source><italic toggle="yes">Database</italic></source>, <volume>2011</volume>, <page-range>bar030</page-range>.</mixed-citation>
    </ref>
    <ref id="R53">
      <label>53.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miranda</surname><given-names>K.C.</given-names></string-name>, <string-name><surname>Huynh</surname><given-names>T.</given-names></string-name>, <string-name><surname>Tay</surname><given-names>Y.</given-names></string-name></person-group><etal>et al.</etal> (<year>2006</year>) <article-title>A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes</article-title>. <source><italic toggle="yes">Cell</italic></source>, <volume>126</volume>, <fpage>1203</fpage>–<lpage>1217</lpage>.<pub-id pub-id-type="pmid">16990141</pub-id></mixed-citation>
    </ref>
    <ref id="R54">
      <label>54.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Paraskevopoulou</surname><given-names>M.D.</given-names></string-name>, <string-name><surname>Georgakilas</surname><given-names>G.</given-names></string-name>, <string-name><surname>Kostoulas</surname><given-names>N.</given-names></string-name></person-group><etal>et al.</etal> (<year>2013</year>) <article-title>DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>41</volume>, <fpage>W169</fpage>–<lpage>W173</lpage>.<pub-id pub-id-type="pmid">23680784</pub-id></mixed-citation>
    </ref>
    <ref id="R55">
      <label>55.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>You</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>D.</given-names></string-name>, <string-name><surname>Ji</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">Clin. Transl. Oncol.</italic></source>, <volume>14</volume>, <fpage>143</fpage>–<lpage>149</lpage>.<pub-id pub-id-type="pmid">22301404</pub-id></mixed-citation>
    </ref>
    <ref id="R56">
      <label>56.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meng</surname><given-names>X.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>P.</given-names></string-name>, <string-name><surname>Mei</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>Expression analysis of miRNA and target mRNAs in esophageal cancer</article-title>. <source><italic toggle="yes">Braz. J. Med. Biol. Res.</italic></source>, <volume>47</volume>, <fpage>811</fpage>–<lpage>817</lpage>.<pub-id pub-id-type="pmid">25098614</pub-id></mixed-citation>
    </ref>
    <ref id="R57">
      <label>57.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cheng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Geng</surname><given-names>H.</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>Y.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>Effects of MiR-210 on proliferation, apoptosis and invasion abilities of esophageal cancer cells</article-title>. <source><italic toggle="yes">J. BUON</italic></source>, <volume>23</volume>, <fpage>814</fpage>–<lpage>819</lpage>.<pub-id pub-id-type="pmid">30003756</pub-id></mixed-citation>
    </ref>
    <ref id="R58">
      <label>58.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Javadinia</surname><given-names>S.A.</given-names></string-name>, <string-name><surname>Shahidsales</surname><given-names>S.</given-names></string-name>, <string-name><surname>Fanipakdel</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>The esophageal cancer and the PI3K/AKT/mTOR signaling regulatory microRNAs: a novel marker for prognosis, and a possible target for immunotherapy</article-title>. <source><italic toggle="yes">Curr. Pharm. Des.</italic></source>, <volume>24</volume>, <fpage>4646</fpage>–<lpage>4651</lpage>.<pub-id pub-id-type="pmid">30636576</pub-id></mixed-citation>
    </ref>
    <ref id="R59">
      <label>59.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Akbarzadeh</surname><given-names>M.</given-names></string-name>, <string-name><surname>Mihanfar</surname><given-names>A.</given-names></string-name>, <string-name><surname>Akbarzadeh</surname><given-names>S.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer</article-title>. <source><italic toggle="yes">Life Sci.</italic></source>, <volume>285</volume>, <fpage>1</fpage>–<lpage>14</lpage>.</mixed-citation>
    </ref>
    <ref id="R60">
      <label>60.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Sun</surname><given-names>K.</given-names></string-name>, <string-name><surname>Chu</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>Long non-coding RNA FTH1P3 regulated metastasis and invasion of esophageal squamous cell carcinoma through SP1/NF-kB pathway</article-title>. <source><italic toggle="yes">Biomed. Pharmacother.</italic></source>, <volume>106</volume>, <fpage>1570</fpage>–<lpage>1577</lpage>.<pub-id pub-id-type="pmid">30119232</pub-id></mixed-citation>
    </ref>
    <ref id="R61">
      <label>61.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Chang</surname><given-names>W.</given-names></string-name></person-group><etal>et al.</etal> (<year>2019</year>) <article-title>MicroRNA-373 promotes the development of esophageal squamous cell carcinoma by targeting <italic toggle="yes">LATS2</italic> and <italic toggle="yes">OXR1</italic></article-title>. <source><italic toggle="yes">Int. J. Biol. Markers</italic></source>, <volume>34</volume>, <fpage>148</fpage>–<lpage>155</lpage>.<pub-id pub-id-type="pmid">30852977</pub-id></mixed-citation>
    </ref>
    <ref id="R62">
      <label>62.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Pan</surname><given-names>T.</given-names></string-name>, <string-name><surname>Zhong</surname><given-names>X.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>Nicotine upregulates microRNA-21 and promotes TGF-<italic toggle="yes">β</italic>-dependent epithelial-mesenchymal transition of esophageal cancer cells</article-title>. <source><italic toggle="yes">Tumor Biol.</italic></source>, <volume>35</volume>, <fpage>7063</fpage>–<lpage>7072</lpage>.</mixed-citation>
    </ref>
    <ref id="R63">
      <label>63.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jia</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhan</surname><given-names>Q.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer</article-title>. <source><italic toggle="yes">J. Mol. Diagn.</italic></source>, <volume>14</volume>, <fpage>577</fpage>–<lpage>585</lpage>.<pub-id pub-id-type="pmid">22921431</pub-id></mixed-citation>
    </ref>
    <ref id="R64">
      <label>64.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>R.</given-names></string-name> and <string-name><surname>Liu</surname><given-names>X.-L.</given-names></string-name></person-group> (<year>2022</year>) <article-title>Roles of Wnt/<italic toggle="yes">β</italic>-catenin signaling pathway related microRNAs in esophageal cancer</article-title>. <source><italic toggle="yes">World J. Clin. Cases</italic></source>, <volume>10</volume>, <fpage>2678</fpage>–<lpage>2686</lpage>.<pub-id pub-id-type="pmid">35434118</pub-id></mixed-citation>
    </ref>
    <ref id="R65">
      <label>65.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Subramaniam</surname><given-names>D.</given-names></string-name>, <string-name><surname>Ponnurangam</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ramamoorthy</surname><given-names>P.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>Curcumin induces cell death in esophageal cancer cells through modulating notch signaling</article-title>. <source><italic toggle="yes">PLoS One</italic></source>, <volume>7</volume>, <fpage>1</fpage>–<lpage>11</lpage>.</mixed-citation>
    </ref>
    <ref id="R66">
      <label>66.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Roychowdhury</surname><given-names>D.</given-names></string-name>, <string-name><surname>Gupta</surname><given-names>S.</given-names></string-name>, <string-name><surname>Qin</surname><given-names>X.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>emiRIT: a text-mining-based resource for microRNA information</article-title>. <source><italic toggle="yes">Database</italic></source>, <volume>2021</volume>, <fpage>1</fpage>–<lpage>20</lpage>.</mixed-citation>
    </ref>
    <ref id="R67">
      <label>67.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ritchie</surname><given-names>W.</given-names></string-name>, <string-name><surname>Flamant</surname><given-names>S.</given-names></string-name> and <string-name><surname>Rasko</surname><given-names>J.E.</given-names></string-name></person-group> (<year>2009</year>) <article-title>Predicting microRNA targets and functions: traps for the unwary</article-title>. <source><italic toggle="yes">Nat. Methods</italic></source>, <volume>6</volume>, <fpage>397</fpage>–<lpage>398</lpage>.<pub-id pub-id-type="pmid">19478799</pub-id></mixed-citation>
    </ref>
    <ref id="R68">
      <label>68.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lewis</surname><given-names>B.P.</given-names></string-name>, <string-name><surname>Shih</surname><given-names>I.H.</given-names></string-name>, <string-name><surname>Jones-Rhoades</surname><given-names>M.W.</given-names></string-name></person-group><etal>et al.</etal> (<year>2003</year>) <article-title>Prediction of mammalian microRNA targets</article-title>. <source><italic toggle="yes">Cell</italic></source>, <volume>115</volume>, <fpage>787</fpage>–<lpage>798</lpage>.<pub-id pub-id-type="pmid">14697198</pub-id></mixed-citation>
    </ref>
    <ref id="R69">
      <label>69.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xu</surname><given-names>W.</given-names></string-name>, <string-name><surname>San Lucas</surname><given-names>A.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>Identifying microRNA targets in different gene regions</article-title>. <source><italic toggle="yes">BMC Bioinform.</italic></source>, <volume>15</volume>, <fpage>1</fpage>–<lpage>11</lpage>.</mixed-citation>
    </ref>
    <ref id="R70">
      <label>70.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name> and <string-name><surname>Chen</surname><given-names>X.</given-names></string-name></person-group> (<year>2021</year>) <article-title>NOTCH and esophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">Adv Exp Med Biol</italic></source>, <volume>1287</volume>, <fpage>59</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="pmid">33034026</pub-id></mixed-citation>
    </ref>
    <ref id="R71">
      <label>71.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Yi</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>K.</given-names></string-name></person-group><etal>et al.</etal> (<year>2017</year>) <article-title>Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">J. Exp. Clin. Cancer Res.</italic></source>, <volume>36</volume>, <fpage>1</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">28049532</pub-id></mixed-citation>
    </ref>
    <ref id="R72">
      <label>72.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>Q.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>MiR-34a-5p inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in esophageal squamous cell carcinoma by targeting lef1 and inactivation of the Hippo-YAP1/TAZ signaling pathway</article-title>. <source><italic toggle="yes">J. Cancer</italic></source>, <volume>11</volume>, <fpage>3072</fpage>–<lpage>3081</lpage>.<pub-id pub-id-type="pmid">32226522</pub-id></mixed-citation>
    </ref>
    <ref id="R73">
      <label>73.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>Y.R.</given-names></string-name>, <string-name><surname>Qi</surname><given-names>H.J.</given-names></string-name>, <string-name><surname>Deng</surname><given-names>D.F.</given-names></string-name></person-group><etal>et al.</etal> (<year>2016</year>) <article-title>MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer</article-title>. <source><italic toggle="yes">Tumor Biol.</italic></source>, <volume>37</volume>, <fpage>12061</fpage>–<lpage>12070</lpage>.</mixed-citation>
    </ref>
    <ref id="R74">
      <label>74.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Izzo</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>T.</given-names></string-name>, <string-name><surname>Malhotra</surname><given-names>U.</given-names></string-name></person-group><etal>et al.</etal> (<year>2006</year>) <article-title>Transcription factor NFkB a potential molecular marker for predicting and improving treatment efficacy in esophageal cancer</article-title>. <source><italic toggle="yes">J. Clin. Oncol.</italic></source>, <volume>24</volume>, <fpage>10065</fpage>–<lpage>10065</lpage>.</mixed-citation>
    </ref>
    <ref id="R75">
      <label>75.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>K.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>X.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells</article-title>. <source><italic toggle="yes">BMC Mol. Biol.</italic></source>, <volume>13</volume>, <fpage>1</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">22248237</pub-id></mixed-citation>
    </ref>
    <ref id="R76">
      <label>76.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Naganuma</surname><given-names>S.</given-names></string-name>, <string-name><surname>Whelan</surname><given-names>K.A.</given-names></string-name>, <string-name><surname>Natsuizaka</surname><given-names>M.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>Notch receptor inhibition reveals the importance of cyclin D1 and Wnt signaling in invasive esophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">Am. J. Cancer Res.</italic></source>, <volume>2</volume>, <fpage>459</fpage>–<lpage>475</lpage>.<pub-id pub-id-type="pmid">22860235</pub-id></mixed-citation>
    </ref>
    <ref id="R77">
      <label>77.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Qi</surname><given-names>B.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Z.J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2017</year>) <article-title>Down-regulation of miR-30a-3p/5p promotes esophageal squamous cell carcinoma cell proliferation by activating the Wnt signaling pathway</article-title>. <source><italic toggle="yes">World J. Gastroenterol.</italic></source>, <volume>23</volume>, <fpage>7965</fpage>–<lpage>7977</lpage>.<pub-id pub-id-type="pmid">29259372</pub-id></mixed-citation>
    </ref>
    <ref id="R78">
      <label>78.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kano</surname><given-names>M.</given-names></string-name>, <string-name><surname>Seki</surname><given-names>N.</given-names></string-name>, <string-name><surname>Kikkawa</surname><given-names>N.</given-names></string-name></person-group><etal>et al.</etal> (<year>2010</year>) <article-title>miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">Int. J. Cancer</italic></source>, <volume>127</volume>, <fpage>2804</fpage>–<lpage>2814</lpage>.<pub-id pub-id-type="pmid">21351259</pub-id></mixed-citation>
    </ref>
    <ref id="R79">
      <label>79.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matsushima</surname><given-names>K.</given-names></string-name>, <string-name><surname>Isomoto</surname><given-names>H.</given-names></string-name>, <string-name><surname>Kohno</surname><given-names>S.</given-names></string-name></person-group><etal>et al.</etal> (<year>2010</year>) <article-title>MicroRNAs and esophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">Digestion</italic></source>, <volume>82</volume>, <fpage>138</fpage>–<lpage>144</lpage>.<pub-id pub-id-type="pmid">20588024</pub-id></mixed-citation>
    </ref>
    <ref id="R80">
      <label>80.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ma</surname><given-names>W.J.</given-names></string-name>, <string-name><surname>Lv</surname><given-names>G.D.</given-names></string-name>, <string-name><surname>Tuersun</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2011</year>) <article-title>Role of microRNA-21 and effect on PTEN in Kazakh’s esophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">Mol. Biol. Rep.</italic></source>, <volume>38</volume>, <fpage>3253</fpage>–<lpage>3260</lpage>.<pub-id pub-id-type="pmid">21104017</pub-id></mixed-citation>
    </ref>
    <ref id="R81">
      <label>81.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matsushima</surname><given-names>K.</given-names></string-name>, <string-name><surname>Isomoto</surname><given-names>H.</given-names></string-name>, <string-name><surname>Yamaguchi</surname><given-names>N.</given-names></string-name></person-group><etal>et al.</etal> (<year>2011</year>) <article-title>miRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells</article-title>. <source><italic toggle="yes">J. Transl. Med.</italic></source>, <volume>9</volume>, <fpage>1</fpage>–<lpage>12</lpage>.</mixed-citation>
    </ref>
    <ref id="R82">
      <label>82.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vecchione</surname><given-names>A.</given-names></string-name>, <string-name><surname>Croce</surname><given-names>C.M.</given-names></string-name> and <string-name><surname>Baldassarre</surname><given-names>G.</given-names></string-name></person-group> (<year>2007</year>) <article-title>Fez1/Lzts1 a new mitotic regulator implicated in cancer development</article-title>. <source><italic toggle="yes">Cell Div.</italic></source>, <volume>2</volume>, <fpage>1</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">17214889</pub-id></mixed-citation>
    </ref>
    <ref id="R83">
      <label>83.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shi</surname><given-names>H.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>R.</given-names></string-name></person-group><etal>et al.</etal> (<year>2016</year>) <article-title>FGF2 regulates proliferation, migration, and invasion of ECA109 cells through PI3K/Akt signalling pathway in vitro</article-title>. <source><italic toggle="yes">Cell Biol. Int.</italic></source>, <volume>40</volume>, <fpage>524</fpage>–<lpage>533</lpage>.<pub-id pub-id-type="pmid">26833879</pub-id></mixed-citation>
    </ref>
    <ref id="R84">
      <label>84.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lui Park</surname><given-names>H.</given-names></string-name>, <string-name><surname>Sook Kim</surname><given-names>M.</given-names></string-name>, <string-name><surname>Yamashita</surname><given-names>K.</given-names></string-name></person-group><etal>et al.</etal> (<year>2008</year>) <article-title>DCC promoter hypermethylation in esophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">Int. J. Cancer</italic></source>, <volume>122</volume>, <fpage>2498</fpage>–<lpage>2502</lpage>.<pub-id pub-id-type="pmid">18302152</pub-id></mixed-citation>
    </ref>
    <ref id="R85">
      <label>85.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>X.J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>D.Y.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Y.</given-names></string-name></person-group><etal>et al.</etal> (<year>1999</year>) <article-title>Mxi1 mutations in human neurofibrosarcomas</article-title>. <source><italic toggle="yes">Jpn. J. Cancer Res.</italic></source>, <volume>90</volume>, <fpage>740</fpage>–<lpage>746</lpage>.<pub-id pub-id-type="pmid">10470286</pub-id></mixed-citation>
    </ref>
    <ref id="R86">
      <label>86.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname><given-names>N.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>C.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>Y.</given-names></string-name></person-group><etal>et al.</etal> (<year>2005</year>) <article-title>Genome-wide association study in esophageal cancer using GeneChip mapping 10k array</article-title>. <source><italic toggle="yes">Cancer Res.</italic></source>, <volume>65</volume>, <fpage>2542</fpage>–<lpage>2546</lpage>.<pub-id pub-id-type="pmid">15805246</pub-id></mixed-citation>
    </ref>
    <ref id="R87">
      <label>87.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jin</surname><given-names>G.</given-names></string-name>, <string-name><surname>Deng</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Miao</surname><given-names>R.</given-names></string-name></person-group><etal>et al.</etal> (<year>2008</year>) <article-title>TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case–control analysis in a Chinese population</article-title>. <source><italic toggle="yes">J. Cancer Res. Clin. Oncol.</italic></source>, <volume>134</volume>, <fpage>345</fpage>–<lpage>351</lpage>.<pub-id pub-id-type="pmid">17680270</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Database (Oxford)</journal-id>
    <journal-id journal-id-type="iso-abbrev">Database (Oxford)</journal-id>
    <journal-id journal-id-type="publisher-id">databa</journal-id>
    <journal-title-group>
      <journal-title>Database: The Journal of Biological Databases and Curation</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-0463</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
      <publisher-loc>UK</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10563827</article-id>
    <article-id pub-id-type="doi">10.1093/database/baad063</article-id>
    <article-id pub-id-type="publisher-id">baad063</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Database Tool</subject>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00960</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Sindhoo</surname>
          <given-names>Asma</given-names>
        </name>
        <aff><institution content-type="department">Department of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University</institution>, Dongchuan Road Minhang District, Shanghai 200240, <country country="CN">PR China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sipy</surname>
          <given-names>Saima</given-names>
        </name>
        <aff><institution>Sindh Madressatul Islam University</institution>, Karachi, Sindh 74600, <country country="PK">Pakistan</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4288-7602</contrib-id>
        <name>
          <surname>Khan</surname>
          <given-names>Abbas</given-names>
        </name>
        <!--abbaskhan@sjtu.edu.cn-->
        <xref rid="COR0001" ref-type="corresp"/>
        <aff><institution content-type="department">Department of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University</institution>, Dongchuan Road Minhang District, Shanghai 200240, <country country="CN">PR China</country></aff>
        <aff><institution content-type="department">State Key Laboratory of Microbial Metabolism, Shanghai–Islamabad–Belgrade Joint Innovation Center on Antibacterial Resistances, Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education and School of Life Sciences and Biotechnology</institution>, Shanghai, Minhang 200030, <country country="CN">PR China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Selvaraj</surname>
          <given-names>Gurudeeban</given-names>
        </name>
        <aff><institution content-type="department">Centre for Research in Molecular Modelling (CERMM), Department of Chemistry and Biochemistry, Concordia University</institution>, Montreal, Quebec H4B 1R6, <country country="CA">Canada</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Alshammari</surname>
          <given-names>Abdulrahman</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University</institution>, Riyadh 11451, <country country="SA">Saudi Arabia</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Casida</surname>
          <given-names>Mark Earl</given-names>
        </name>
        <aff><institution content-type="department">Laboratoire de Spectrom´etrie, Interactions et Chimie th´eorique (SITh), D´epartement de Chimie Mol´eculaire (DCM, UMR CNRS/UGA 5250), Institut de Chimie Mol´eculaire de Grenoble (ICMG, FR2607), Universit´e Grenoble Alpes (UGA)</institution>, 301 rue de la Chimie BP 53, Grenoble Cedex F-38041, <country country="FR">France</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Wei</surname>
          <given-names>Dong-Qing</given-names>
        </name>
        <!--dqwei@sjtu.edu.cn-->
        <aff><institution content-type="department">Department of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University</institution>, Dongchuan Road Minhang District, Shanghai 200240, <country country="CN">PR China</country></aff>
        <aff><institution content-type="department">State Key Laboratory of Microbial Metabolism, Shanghai–Islamabad–Belgrade Joint Innovation Center on Antibacterial Resistances, Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education and School of Life Sciences and Biotechnology</institution>, Shanghai, Minhang 200030, <country country="CN">PR China</country></aff>
        <aff><institution>Peng Cheng Laboratory</institution>, Phase I Building 8, Xili Street, Montreal, Vanke Cloud City, Nashan District, Shenzhen, Guangdong 518055, <country country="CN">PR China</country></aff>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR0001">*Corresponding author: Tel: +8613482132323; Email: <email xlink:href="abbaskhan@sjtu.edu.cn">abbaskhan@sjtu.edu.cn</email>Correspondence may also be addressed to Dong-Qing Wei. Email: <email xlink:href="dqwei@sjtu.edu.cn">dqwei@sjtu.edu.cn</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2023-10-10">
      <day>10</day>
      <month>10</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>10</day>
      <month>10</month>
      <year>2023</year>
    </pub-date>
    <volume>2023</volume>
    <elocation-id>baad063</elocation-id>
    <history>
      <date date-type="received">
        <day>12</day>
        <month>5</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>10</day>
        <month>7</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>16</day>
        <month>9</month>
        <year>2023</year>
      </date>
      <date date-type="editorial-decision">
        <day>04</day>
        <month>8</month>
        <year>2023</year>
      </date>
      <date date-type="corrected-typeset">
        <day>10</day>
        <month>10</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="baad063.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>‘Esophageal cancer’ (EC) is a highly aggressive and deadly complex disease. It comprises two types, esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC), with Barrett’s esophagus (BE) being the only known precursor. Recent research has revealed that microRNAs (miRNAs) play a crucial role in the development, prognosis and treatment of EC and are involved in various human diseases. Biological databases have become essential for cancer research as they provide information on genes, proteins, pathways and their interactions. These databases collect, store and manage large amounts of molecular data, which can be used to identify patterns, predict outcomes and generate hypotheses. However, no comprehensive database exists for EC and miRNA relationships. To address this gap, we developed a dynamic database named ‘ESOMIR (miRNA in esophageal cancer) (<ext-link xlink:href="https://esomir.dqweilab-sjtu.com" ext-link-type="uri">https://esomir.dqweilab-sjtu.com</ext-link>)’, which includes information about targeted genes and miRNAs associated with EC. The database uses analysis and prediction methods, including experimentally endorsed miRNA(s) information. ESOMIR is a user-friendly interface that allows easy access to EC-associated data by searching for miRNAs, target genes, sequences, chromosomal positions and associated signaling pathways. The search modules are designed to provide specific data access to users based on their requirements. Additionally, the database provides information about network interactions, signaling pathways and region information of chromosomes associated with the 3ʹuntranslated region (3ʹUTR) or 5ʹUTR and exon sites. Users can also access energy levels of specific miRNAs with targeted genes. A fuzzy term search is included in each module to enhance the ease of use for researchers. ESOMIR can be a valuable tool for researchers and clinicians to gain insight into EC, including identifying biomarkers and treatments for this aggressive tumor.</p>
      <p>
        <bold>Database URL</bold>
        <ext-link xlink:href="https://esomir.dqweilab-sjtu.com" ext-link-type="uri">https://esomir.dqweilab-sjtu.com</ext-link>
      </p>
    </abstract>
    <counts>
      <page-count count="12"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec id="s1">
    <title>Introduction</title>
    <p>Esophageal cancer (EC) is one of the deadliest cancers. In 2020, EC was responsible for 0.54 million deaths with 0.6 million new cases worldwide according to Global Cancer Statistics 2020: GLOBOCAN estimation (<xref rid="R1" ref-type="bibr">1</xref>). Histologically, in EC, there are two subtypes: esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC) (<xref rid="R2" ref-type="bibr">2</xref>). However, it is believed that Barrett’s esophagus (BE) is the only precursor to EAC (<xref rid="R3" ref-type="bibr">3</xref>). Both subtypes seem very different due to distinctive primary risks, time trends, geographical patterns and genetic associations (<xref rid="R4" ref-type="bibr">4</xref>). The multistep process of EC development (ESCC and EAC) involves genetic occurrences that lead to important abnormalities in cell cycle control, neurotrophic interaction and adhesion molecules mechanisms (<xref rid="R5" ref-type="bibr">5</xref>). The occurrence of ESCC is predominant in Asian and sub-Sahara African regions, while EAC is predominant in Western countries (<xref rid="R1" ref-type="bibr">1</xref>).</p>
    <p>MicroRNAs (miRNAs) are short [18–24 nucleotides (nt)] intrinsic non-coding RNAs that could control the gene transcription, i.e. pre-regulation of genes. miRNAs are a set of smallest single-stranded non-coding molecules among its other types, with 21–25 nt that regulate genes post-transcription in various species (<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R7" ref-type="bibr">7</xref>). miRNA plays a key role in regulating biological, physiological and cellular developmental processes, including apoptosis, cell proliferation, differentiation, invasion, metastasis, metabolism, tumorigenic progression, resisting cell death and stem cell maintenance (<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R9" ref-type="bibr">9</xref>). miRNA is the crucial player that can act as a tumor suppressor or oncogenes after being downregulated or upregulated (<xref rid="R10" ref-type="bibr">10</xref>). In a recent study, most miRNA gene mutations are typically found in genomic regions linked to cancer (<xref rid="R11" ref-type="bibr">11</xref>). Unfortunately, EC (subtypes ESCC and EAC) is diagnosed at an advanced or metastatic stage in most cases due to its asymptomatic nature, resulting in a poor prognosis and a high-death rate (<xref rid="R12" ref-type="bibr">12</xref>).</p>
    <p>Recent advancement in tumorigenesis shows that molecular mechanism studies play a vital role in understanding insight into cancer (<xref rid="R13" ref-type="bibr">13</xref>). Molecular biomarkers are potential solutions for improving cancer invasion, metastasis and prognosis (<xref rid="R14" ref-type="bibr">14–16</xref>). miRNAs seem revolutionary discoveries for cancer treatment as miRNA acts as a regulator of gene expression. miRNA target identification has been a prominent area of research in recent years to gain insights into the signaling pathways, genes and mechanisms involved in cancer (<xref rid="R17" ref-type="bibr">17–21</xref>). miRNA prediction in vertebrates is complex as they have irregular homology in the target sequence on the seed region (<xref rid="R22" ref-type="bibr">22</xref>). There is substantial evidence that miRNAs play a critical role in the development of EC (<xref rid="R23" ref-type="bibr">23–26</xref>). miRNAs have also been utilized to classify EC based on the stage or type (<xref rid="R27" ref-type="bibr">27</xref>).</p>
    <p>MiRNAs identified through computational methods and subsequently validated through experimental methods have the highest potential to alleviate the underlying mechanisms involved in cancer hallmarks. Several miRNA discoveries associated with EC networks have shown promising results for prognosis, diagnosis and treatment. There is a growing demand for a user-friendly knowledge repository containing all relevant information, including miRNAs, genes, pathways, targets, networks and more (<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R7" ref-type="bibr">7</xref>).</p>
    <p>Several databases are available to provide chromosomal-based information associated with targeted messenger RNA (mRNA), cancer pathways and lists of miRNAs. Some comprehensive databases, such as miRBase (<xref rid="R28" ref-type="bibr">28</xref>), miRGen v.3 (<xref rid="R29" ref-type="bibr">29</xref>) and MiRGator v 3.0 (<xref rid="R30" ref-type="bibr">30</xref>), provide annotated sequences, nomenclature and target information. Manually curated databases, including miRWalk (<xref rid="R31" ref-type="bibr">31</xref>), miRTarbase (<xref rid="R32" ref-type="bibr">32</xref>), miRNAMap (<xref rid="R33" ref-type="bibr">33</xref>) and mirRecord (<xref rid="R34" ref-type="bibr">34</xref>), offer experimentally validated perspectives on associated miRNAs, their interactions and targets. Additionally, there are computationally targeted prediction-based databases, such as TargetScan (<xref rid="R35" ref-type="bibr">35</xref>), miRDB (<xref rid="R36" ref-type="bibr">36</xref>), PicTar (<xref rid="R37" ref-type="bibr">37</xref>) and MirRabel (<xref rid="R38" ref-type="bibr">38</xref>). Several disease-specific databases exist to fulfill the needs of miRNA repositories, such as OncomiRdbB (<xref rid="R39" ref-type="bibr">39</xref>), miRCancer (<xref rid="R40" ref-type="bibr">40</xref>), miRactDB (<xref rid="R41" ref-type="bibr">41</xref>), PhenoMir (<xref rid="R42" ref-type="bibr">42</xref>), HDMM (<xref rid="R43" ref-type="bibr">43</xref>) and S-MED (<xref rid="R44" ref-type="bibr">44</xref>). However, these databases focus on different cancer types and provide detailed information about those diseases. Unfortunately, no detailed repository is available to provide insightful information about miRNAs involved in EC and its subtypes. Therefore, we developed and designed a comprehensive miRNA-based repository for researchers to access mRNA–miRNA targets, signaling pathways and targeted gene ontologies for EC. We created a web-based repository/database with a graphical user interface called ESOMIR (<ext-link xlink:href="https://esomir.dqweilab-sjtu.com" ext-link-type="uri">https://esomir.dqweilab-sjtu.com</ext-link>). Our database contains 877 human miRNAs and 133 mRNAs that act as miRNA targets in various signaling pathways, and we used MirWalk and TargetScan to cross-validate the putative targets for miRNAs. ESOMIR is a promising tool for the diagnostic paradigm in EC as it is a unique, comprehensive data repository freely accessible to everyone.</p>
  </sec>
  <sec id="s2">
    <title>Database design and structure</title>
    <sec id="s2-s1">
      <title>Quarrying and categorizing miRNAs and their associated targets</title>
      <p>We mined all miRNAs from literature and various databases, specifically MirTarbase, MiRDB, miRBase, MicroCosm, miR2Disease (<xref rid="R45" ref-type="bibr">45</xref>) and miRSystem (<xref rid="R46" ref-type="bibr">46</xref>). We wrote a function in Python to exclude duplicated entries and used a script to acquire all mature miRNA FASTA sequences from miRBase. We extracted the targeted sites (3′UTRs, 5′UTRs and exons) of oncogenes from literature and knowledge systems such as COSMIC (Catalogue of Somatic Mutations in Cancer) (<xref rid="R47" ref-type="bibr">47</xref>), KEGG (Kyoto Encyclopedia of Genes and Genomes) (<xref rid="R48" ref-type="bibr">48</xref>), DDEC (Dragon Database of Genes Implicated in Esophageal Cancer) (<xref rid="R49" ref-type="bibr">49</xref>), CGED (Cancer Gene Expression Database) (<xref rid="R50" ref-type="bibr">50</xref>) and DisGenNet (<xref rid="R51" ref-type="bibr">51</xref>). We used the Ensembl-BioMart tool (<xref rid="R52" ref-type="bibr">52</xref>) to download the FASTA sequence of all oncogenes. Then, we screened 2654 miRNAs against EC oncogenes using miRanda (<xref rid="R53" ref-type="bibr">53</xref>), DIANA-microT-CDS (<xref rid="R54" ref-type="bibr">54</xref>) and RNA22 v2. We identified potential miRNAs and their target sites based on the standard scores set for an appropriate target. After the screening, we used the KEGG database to find signaling pathways against each putative target. We illustrated the complete workflow from data mining to processing, prediction and validation used in the study in <xref rid="F1" ref-type="fig">Figure 1</xref>.</p>
      <fig position="float" id="F1" fig-type="figure">
        <label>Figure 1.</label>
        <caption>
          <p>This diagram illustrates the ESOMIR modules, representing data analysis, prediction and mining procedures. Each stage in the process is clearly defined in this schematic, outlining the steps taken to reach the desired outcome.</p>
        </caption>
        <graphic xlink:href="baad063f1" position="float"/>
      </fig>
    </sec>
    <sec id="s2-s2">
      <title>The structure of database and its contents</title>
      <p>Database development is complex when providing a cognate database to users via a web-based interface with processing accuracy and speed. We developed and designed a database structure that allows users to access and extract information about miRNAs and their targets for human EC. We designed and developed ESOMIR as a cloud-based web portal to give access to in-depth analyzed data. The user interface of ESOMIR is user-friendly, which allows easy access to efficient information. We designed the structure of ESOMIR using PHP, MySQL, HTML, DataTables, Ajax, Bootstrap and jQuery.</p>
      <sec id="s2-s2-s1">
        <title>Back-end development</title>
        <p>We used the XAMPP server to design a cloud-based online portal, integrating parts such as Apache server, database (MySQL) and web interface. We developed the online portal using two scripting languages (PHP and HTML). We used MySQL and DataTables for data storage and associated operations. Additionally, we implemented logical scripts to search miRNAs, target genes or associated pathways to EC to develop the data extraction module (<xref rid="F1" ref-type="fig">Figure 1</xref>). ESOMIR is directly linked to an original database, allowing users to access direct data. ESOMIR offers multiple particulars to access data associated with EC, including miRNAs, accession number, oncogene, target sites, description of genes and chromosome location.</p>
      </sec>
      <sec id="s2-s2-s2">
        <title>Front-end development</title>
        <p>The primary purpose of the ESOMIR interface is to provide intelligent interaction with a portal that gives the user a sense of acceptance. Ease and clarity are the foremost priorities to provide no-effort access to every group of users and enough technical assistance to do bioinformatics analysis with efficacy and effortlessness. We used Cascading Style Sheets (CSS), JavaScript, DataTables and Bootstrap to provide a modern look to this online portal.</p>
      </sec>
    </sec>
    <sec id="s2-s3">
      <title>Selection and validation of miRNAs as putative EC miRNAs</title>
      <p>In order to categorize potential miRNAs associated with EC, we performed prediction and analysis against all collected oncogenes using miRanda, RNA22v2 and DIANA-microT-CDS. To mine putative miRNAs, we established specific parameters for each algorithm. In miRanda, we set the analysis parameter to −15 kcal/mol energy level (EL) with a threshold of 120. The miRanda algorithm has standard settings for reasonably predicting potential target sites. The free energy of RNA molecules, which is involved in unfolding the interaction sites to allow the pairing of nucleotides between miRNAs and mRNAs, is an essential property that facilitates their interactions. Therefore, lower overall free energy means higher miRNA–mRNA complex stability, indicating a higher possibility of essential interactions.</p>
      <p>For RNA22v2, we selected entities with a folding energy of −12 with a <italic toggle="yes">P</italic>-value of 0.1 and more than three seeds. Additionally, we chose a threshold of 0.7 with a score of 90 using DIANA-microT-CDS, as this is the suggested threshold range for sensitive analysis for significant results. After all selection and analysis, we identified 2028 potential miRNAs and their associated target genes and pathways for EC. We excluded data entries that did not meet the inclusion criteria and all microRNA entities that did not meet the mentioned criteria. To assess the significance of ECOMIR among other existing database systems, we plot a comparison graph in <xref rid="F2" ref-type="fig">Figure 2A</xref>. We further validated the resulting miRNAs through miRWALK and TargetScan, where only experimentally validated connections were considered putative miRNAs.</p>
      <fig position="float" id="F2" fig-type="figure">
        <label>Figure 2.</label>
        <caption>
          <p>(<bold>A</bold>) Comparison of all available miRNA targets associated with EC in ESOMIR and other available databases. The figure shows that ESOMIR has the highest number of miRNAs included in contrast to the other available databases. (<bold>B</bold>) Comparison of all available mRNAs associated with EC in ESOMIR and other available databases.</p>
        </caption>
        <graphic xlink:href="baad063f2" position="float"/>
      </fig>
    </sec>
    <sec id="s2-s4">
      <title>Target-based network enrichment analysis via KEGG pathways</title>
      <p>EC is known to be regulated by different signaling pathways via microRNA, which have been shown to be significant players in the development of this disease (<xref rid="R55" ref-type="bibr">55–65</xref>). Using miRanda via KEGG, we identified some critical pathways in ESOMIR, including Wnt, NF-κB, TGFB, Apoptosis, Hippo, JAK-STAT and NOTCH, based on different ELs and a 120-threshold score. To ensure accuracy, we employed MirWalk and TargetScan for additional validation. In total, we identified 107 genes as miRNA targets across all signaling pathways in humans with EC. ESOMIR includes a higher number of genes as targets for EC-specific miRNAs compared to other cancer databases such as MirCosm, emiRiT (<xref rid="R66" ref-type="bibr">66</xref>), Mir2Disease, MirSystem, HMDD v2.0 (<xref rid="R43" ref-type="bibr">43</xref>) and miRCancer database (<xref rid="F2" ref-type="fig">Figure 2B</xref>).</p>
      <p>Among all signaling pathways, mTOR, apoptosis and NF-κB recorded the highest number of targeted mRNA–miRNA associated with EC, while NOTCH signaling had the least number of targets (<xref rid="F3" ref-type="fig">Figure 3</xref>). A single miRNA can target one or several genes, or several miRNAs can access a single target gene. Therefore, studying all signaling pathways associated with EC, either miRNA or mRNA, can lead to exciting discoveries. Further exploration of the interaction between miRNA–mRNA via signaling pathways could provide an in-depth understanding of possible miRNA–mRNA regulation. Considering the significant role of miRNAs in regulating mRNAs in disease development, we utilized data on miRNAs and their targets in each signaling pathway to recognize their interaction. To showcase the miRNA and target interaction, we proposed a binary matrix for each signaling pathway, with 1 indicating an mRNA targeted by miRNA and 0 indicating an mRNA not targeted. We then converted the miRNA–mRNA targets data frame into a matrix to extract error-free data using an open-source Bioconductor package of R.</p>
      <fig position="float" id="F3" fig-type="figure">
        <label>Figure 3.</label>
        <caption>
          <p>Signaling pathway targeted by selected putative miRNA associated with EC. The respective pathways along with their percentages are given and represented by different colors.</p>
        </caption>
        <graphic xlink:href="baad063f3" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec id="s3">
    <title>Results</title>
    <p>ESOMIR is a comprehensive database that extensively explores multiple paramount features related to EC information. The database contains a rich compilation of 125 unique genes and 877 miRNA targets implicated in EC. Accessible through a web-based portal, the database offers users access to various columns, each providing further details on the specific entity or entry under investigation. These columns include miRNA, accession, target site, EL, gene and associated information, chromosomal location and signaling pathway. Consequently, ESOMIR offers a holistic understanding of EC-related data.</p>
    <sec id="s3-s1">
      <title>Structure of the ESOMIR database modules</title>
      <p>We intentionally designed the homepage of ESOMIR to exhibit simplicity and comprehensiveness regarding EC information. Additionally, we presented abstract information about the project. The webpage comprises a header, footer, responsive side navigation bar and body. A Toggle button is incorporated to facilitate the users in showing or hiding the navigation bar. The side navigation bar serves as the primary menu, enabling users to access different options promptly. We provide five pages, including the homepage, search page, statistics page, help page and contact us page. To provide a visual representation of the home page, we illustrate <xref rid="F4" ref-type="fig">Figure 4</xref>.</p>
      <fig position="float" id="F4" fig-type="figure">
        <label>Figure 4.</label>
        <caption>
          <p>ESOMIR Homepage: a comprehensive miRNA database for EC. The home page shows the description of the database with different tabs that are included in the database. The Fuzzy Search Functionality implemented in ESOMIR is also given.</p>
        </caption>
        <graphic xlink:href="baad063f4" position="float"/>
      </fig>
    </sec>
    <sec id="s3-s2">
      <title>Fuzzy search</title>
      <p>On every page of ESOMIR, we provide a quick fuzzy term–based search to provide quick access to users. Users can give a minimum of three characters and get the results. Users can search in any context and retrieve any data record associated with EC. We implemented fuzzy search to ease the users who might need to search for the whole term or misspell it. This approach presents relevant results to the user. <xref rid="F4" ref-type="fig">Figure 4</xref> demonstrates the representation of fuzzy search.</p>
    </sec>
    <sec id="s3-s3">
      <title>Database gateways</title>
      <p>ESOMIR’s search page provides users with three methods to access and retrieve miRNA and their target information. The first approach involves an miRNA-based search, which offers users a selection of miRNA-related options, such as miRBase ID, accession or mature sequence. We make these options available through a drop-down menu and a search bar that users can utilize to filter or narrow their search based on specific data. The second option is gene-centric, enabling users to refine their search by selecting the gene symbol, Ensembl ID or Entrez ID. Enter the corresponding gene in the search box for specific gene data. The third and final method ESOMIR’s search page provides is interaction-network-based, which provides users with signaling pathways. The interaction-network-based method enables users to explore the signaling pathways associated with genes, miRNA and interaction by selecting pathways from a drop-down menu. Notable pathways include Wnt, NF-κB, TGFB, Apoptosis, Hippo, JAK-STAT and NOTCH. <xref rid="F5" ref-type="fig">Figure 5</xref> offers a comprehensive representation of ESOMIR’s search page.</p>
      <fig position="float" id="F5" fig-type="figure">
        <label>Figure 5.</label>
        <caption>
          <p>Demonstrative depiction of the Search page to access data using different modules. In the above figure from the database, it can be seen that the information can be retrieved through search by miRNA identifier search, search by target gene or miRNA or search for miRNA targeted pathway.</p>
        </caption>
        <graphic xlink:href="baad063f5" position="float"/>
      </fig>
    </sec>
    <sec id="s3-s4">
      <title>Upshot of data approachability</title>
      <p>The tabular format presents the search results, including columns for miRNA, mRNA and associated information. The first column displays the miRNA and its accession number, which serves as a redirecting link to <ext-link xlink:href="http://www.mirbase.org" ext-link-type="uri">www.mirbase.org</ext-link>. The table also shows the target sites, indicating the predicted target site of an miRNA gene, which can be 3ʹUTR, 5ʹUTR or exon. Additionally, there is a column that provides information on ELs in kcal/mol. The respective columns illustrate the associated pathways. Targeted gene information is available through a link that redirects to GenAtlas.</p>
      <p>Furthermore, the table provides accessibility links to <ext-link xlink:href="http://www.ensembl.org" ext-link-type="uri">www.ensembl.org</ext-link> and <ext-link xlink:href="http://www.biogps.org" ext-link-type="uri">www.biogps.org</ext-link>, allowing users to access the customizable layout through Ensembl ID and Entrez ID columns. The chromosome column provides the chromosomal location, with an accessible link to GeneCards, for users to obtain a broader vision of gene-centric information. The signaling pathways column maps the associated pathways of the specific miRNA, and users can also map the target gene onto the pathway in EC. The analysis includes vital pathways such as Wnt, NF-κB, TGFB, Apoptosis, Hippo, JAK-STAT and NOTCH. Users can access more detailed information about a specific pathway by being redirected to the KEGG pathway site. The resulting window provides pertinent information on crucial EC miRNAs and their well-recognized targets at various ELs. This information is deposited on the pathway information result page for users to access effortlessly. Target-based pathway information is available as an image file, which users can view in <xref rid="F6" ref-type="fig">Figure 6</xref>. The target pathway search module presents pathway results that differ from other modules. It presents information about miRNA–mRNA with 3ʹUTR, 5′UTR and exon in a network with associated nodes and connections. The target pathway search module presents pathway results that differ from other modules. It presents information about miRNA–mRNA with 3′UTR, 5ʹUTR and exon in a network with associated nodes and connections as shown in <xref rid="F7" ref-type="fig">Figure 7</xref>.</p>
      <fig position="float" id="F6" fig-type="figure">
        <label>Figure 6.</label>
        <caption>
          <p>An illustration of the ESOMIR result page presented in a tabular format. The results show the miRNA, accession ID, target site, EL and other information including the gene name and pathways.</p>
        </caption>
        <graphic xlink:href="baad063f6" position="float"/>
      </fig>
      <fig position="float" id="F7" fig-type="figure">
        <label>Figure 7.</label>
        <caption>
          <p>A depiction of the search results for the apoptosis signaling pathway, showcasing the target miRNA–mRNA network.</p>
        </caption>
        <graphic xlink:href="baad063f7" position="float"/>
      </fig>
    </sec>
    <sec id="s3-s5">
      <title>The importance and abundance of data represented in ESOMIR</title>
      <p>The abundance and importance of data in the ESOMIR database are by its large number of entries, which reflects the large number of studies that have been investigated to collect, validate and verify miRNA–target interactions associated with EC. The database currently includes &gt;2000 miRNA–target interactions curated from various sources, including experimental studies, computational predictions and literature mining. The density of data can be viewed in <xref rid="F8" ref-type="fig">Figure 8</xref>.</p>
      <fig position="float" id="F8" fig-type="figure">
        <label>Figure 8.</label>
        <caption>
          <p>An illustration of &gt;2000 mRNA–miRNA interactions that are exclusively linked to EC in the ESOMIR database.</p>
        </caption>
        <graphic xlink:href="baad063f8" position="float"/>
      </fig>
      <p>The diverse information available in the ESOMIR database, including miRNA–target interactions along with their associated signaling pathways, is shown in <xref rid="F9" ref-type="fig">Figure 9</xref>. This vast collection of information can be used to investigate the regulatory networks of miRNAs and their target genes in various biological processes, such as development, differentiation and disease. By utilizing the ESOMIR database, researchers can gain insight into the complex mechanisms underlying miRNA-mediated gene regulation and its role in disease pathogenesis, which could lead to the identification of potential therapeutic targets.</p>
      <fig position="float" id="F9" fig-type="figure">
        <label>Figure 9.</label>
        <caption>
          <p>A depiction of the miRNA–target interactions, along with their corresponding signaling pathways.</p>
        </caption>
        <graphic xlink:href="baad063f9" position="float"/>
      </fig>
      <p>Furthermore, we selected the key gene and key miRNA on the basis of binding site, rank score, number of targets and ELs. We illustrated the top 10% targeted/selected genes and miRNAs associated with EC. Few listed miRNAs are hsa-miR-6807-3p, hsa-miR-133a-3p, hsa-miR-6809-3p, hsa-miR-6867-5p, hsa-miR-6511a-5p, hsa-miR-92a-3p, hsa-miR-6738-3p, hsa-miR-7854-3p, hsa-miR-145-5p, hsa-miR-181b-5p, hsa-miR-183-5p, hsa-miR-544b, hsa-miR-6512-3p, hsa-miR-6758-5p, hsa-miR-6847-5p, hsa-miR-6893-5p, hsa-miR-106b-5p, hsa-miR-183-3p, hsa-miR-320b, hsa-miR-320c, hsa-miR-34a-5p, hsa-miR-107, hsa-miR-16-1-3p, hsa-miR-181d-5p, hsa-miR-200a-3p, hsa-miR-485-5p, hsa-miR-107, hsa-miR-124-3p, hsa-miR-200b-3p, hsa-miR-21-3p, hsa-miR-30a-3p, hsa-miR-92b-3p and hsa-miR-93-5p, and genes are BRCA1, CTNNA1, DCC, FGF2, HMOX1, LZTS1, MXI1, PTEN, RNF6 and TGFBR2. We illustrated the associations using a network as shown in <xref rid="F10" ref-type="fig">Figure 10C</xref>. However, top 10% gene with highest score can be seen in <xref rid="F10" ref-type="fig">Figure 10A</xref> and top 10% miRNA can be seen in <xref rid="F10" ref-type="fig">Figure 10B</xref>.</p>
      <fig position="float" id="F10" fig-type="figure">
        <label>Figure 10.</label>
        <caption>
          <p>An illustration of top key mRNA and miRNA targets associated with EC. (<bold>A</bold>) The top 10% identified genes associated with EC. (<bold>B</bold>) The top 10% identified miRNAs associated with EC. (<bold>C</bold>) A network that visualizes the top connections and associations between mRNA and miRNAs, highlighting the most significant interactions among them.</p>
        </caption>
        <graphic xlink:href="baad063f10" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec id="s4">
    <title>Discussion</title>
    <p>Biological data have become a critical resource for studying complex diseases, with numerous databases available to target specific diseases and associated data. However, while miRNAs-based databases and their targets are essential, only some compile comprehensive knowledge about specific diseases and their targets. Currently, no available database exclusively provides information on the association of miRNAs with EC. To address this, we have developed ESOMIR, a dynamic and user-friendly database that provides comprehensive information on predicted and experimentally validated miRNAs with their putative targets. This database is anticipated to aid in the discovery of potential biomarkers for EC that possess diagnostic and therapeutic characteristics. Compared to other databases such as MicroCosm, miR2Disease, eMirit, TargetScan, HMDD v2.0 and miRCancer, ESOMIR contains the highest number of EC-specific miRNAs, with 877 humans (<xref rid="F2" ref-type="fig">Figure 2A</xref>). This research also introduces novel miRNAs with their target information in different pathways. The ESOMIR database has a user-friendly web interface that enables the query of miRNAs, target mRNAs and their interaction network. Additionally, it provides target-ontology information for all genes in oncogenic pathways, making it a widespread platform for studying miRNA and its alleged role in the development and progression of EC. The identification and functional prediction of miRNA targets is essential in assessing the role of miRNAs in regulating or deregulating common genes and pathways that contribute to cancer development (<xref rid="R67" ref-type="bibr">67</xref>). Despite the continuous evolution of miRNA target prediction algorithms, effective prediction of miRNA targets in animals remains more challenging than in plants (<xref rid="R68" ref-type="bibr">68</xref>). miRNAs regulate target genes by binding to their 3ʹUTR, 5ʹUTR or coding regions through the seed region (5ʹ ends of miRNA), making it a more difficult task for target prediction tools because of incomplete base pairing at the complementary site (<xref rid="R69" ref-type="bibr">69</xref>). To minimize false positives, we employed a well-known target prediction algorithm, miRanda, RNA22v2 and DIANA-microR-CDS at different ELs, with validation by mirWalk and TargetScan. Targets predicted at the lowest EL 30 represent a strong pairing of miRNA to its target, whereas EL 15 is a more relaxed criterion for finding novel miRNA targets. This approach can help researchers narrow down and screen the most promising putative miRNA targets in acute lymphoblastic leukemia for validation. We found that the ESOMIR database contains 123 miRNA targets for humans, representing the highest number of predicted putative targets for EC miRNAs compared to any other available database (<xref rid="F2" ref-type="fig">Figure 2B</xref>). Down-regulation of a wide range of oncogenes through miRNAs involved in different signaling pathways can maintain the healthy background of normal cells. Therefore, classifying EC miRNA targets based on different signaling pathways and interpreting miRNA–mRNA interaction networks at 3ʹUTR, 5ʹUTR and exon regions of target genes could provide detailed information on the role of miRNAs in EC initiation and progression. Several studies demonstrate the interaction between miRNA and signaling pathways during all procedures/hallmarks in EC. For instance, Li <italic toggle="yes">et al.</italic> reported cross-interaction between miRNA and NOTCH signaling in EC, specifically in ESCC (<xref rid="R70" ref-type="bibr">70</xref>). Moreover, Gao <italic toggle="yes">et al.</italic> demonstrated that the overexpression of miR-31 is an oncogene in ESCC, repressing the expression of LATS2 by the Hippo pathway and activating epithelial–mesenchymal transition (<xref rid="R71" ref-type="bibr">71</xref>).</p>
    <p>According to the ESOMIR database, the interaction between miRNA–mRNA networks in different signaling pathways is crucial in facilitating cross talks, for example, miR-34a-5p inhibits proliferation, migration, invasion and epithelial–mesenchymal transition in ESCC by targeting LEF1 and inactivating the Hippo–YAP1/TAZ Signaling Pathway (<xref rid="R72" ref-type="bibr">72</xref>). miRNA-373 also promotes the development of ESCC by targeting LATS2 and OXR1. Furthermore, miRNA-21 promotes cell proliferation, migration and resistance to apoptosis in EC through the PTEN/PI3K/AKT signaling pathway (<xref rid="R58" ref-type="bibr">58</xref>, <xref rid="R73" ref-type="bibr">73</xref>). The mTOR pathway and its interaction networks are identified as potential therapeutic targets in the treatment of EC (<xref rid="R59" ref-type="bibr">59</xref>). Researchers have identified the NF-κB signaling pathway as a transcriptional activator for a potential molecular marker for predicting and improving treatment efficacy in EC (<xref rid="R74" ref-type="bibr">74–76</xref>). The researchers have defined the roles of Wnt/β-catenin signaling pathway–related miRNAs in EC (<xref rid="R64" ref-type="bibr">64</xref>). They have found that down-regulation of miR-30a-3p/5p by activating the Wnt signaling pathway promotes cell proliferation in ESCC (<xref rid="R77" ref-type="bibr">77</xref>).</p>
    <p>Various miRNAs are considered tumor suppressors or oncogenes in EC, including miR-10ab, miR-133ab, miR-145, miR-205, miR-99b, miR-199a-3p, miR-199a-5p, miR-126, miR-16-2, miR-15b, miR-143, miR-233, miR-486-5p and let-7a, as well as PDCD4, PTEN, ZEB1, Lzts, FGF2, DCC, MXI1, RNF6 and TGFB (<xref rid="R78" ref-type="bibr">78–87</xref>). The ESOMIR database provides information about these critical biomarkers and their associated targets. The functional annotation of miRNA targets at different cellular and molecular levels is essential for a systematic ontology of miRNAs. The ESOMIR database assigns ontology to targets of miRNAs and their association with biological processes at the cellular and molecular levels. Exploring relations between miRNA target genes and diseases could simplify our understanding of the pathogenesis of cancer and its progression. This information could help further understand the role of the miRNA cluster in regulating diverse pathways, leading to the development of novel therapeutic regimens for EC.</p>
  </sec>
  <sec id="s5">
    <title>Conclusion</title>
    <p>The ESOMIR database is a valuable resource for researchers and clinicians interested in studying miRNA–target interactions associated with EC. With &gt;2000 meticulously curated miRNA–target interactions, this database provides a wealth of information on the regulatory networks of miRNAs and their target genes in various biological processes. The database uses analysis and prediction methods, including experimentally endorsed miRNA(s) information. ESOMIR is a user-friendly interface that allows easy access to EC-associated data by searching for miRNAs, target genes, sequences, chromosomal positions and associated signaling pathways. The search modules are designed to provide specific data access to users based on their requirements. Additionally, the database provides information about network interactions, signaling pathways and region information of chromosomes associated with the 3ʹUTR or 5ʹUTR and exon sites. Overall, the ESOMIR database is a promising platform for identifying potential therapeutic targets and developing personalized cancer treatments. In addition to the current features and information in the ESOMIR database, future updates could include additional data on miRNA–target interactions associated with other types of cancers or diseases. These updates would further expand the database’s usefulness and make it a more comprehensive resource for researchers and clinicians. Additionally, incorporating machine learning algorithms could help to identify novel miRNA–target interactions and further enhance the predictive power of the database.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>baad063_Supp</label>
      <media xlink:href="baad063_supp.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>Authors are thankful to the Researchers Supporting Project number (RSP2023R491), King Saud University, Riyadh, Saudi Arabia.</p>
  </ack>
  <sec id="s6">
    <title>Supplementary material</title>
    <p><xref rid="sup1" ref-type="supplementary-material">Supplementary material</xref> is available at <italic toggle="yes">Database</italic> online.</p>
  </sec>
  <sec sec-type="data-availability" id="s7">
    <title>Data availability</title>
    <p>The data used to develop the database is attached as a supplementary file.</p>
  </sec>
  <sec id="s8">
    <title>Funding</title>
    <p>National Key R&amp;D Program of China (2021YFA0911500); Shanghai Pujiang Program (21PJ1405100); National Science Foundation of China (32070662, 61832019, 32030063) to D.-Q.W.; Science and Technology Commission of Shanghai Municipality (19430750600); SJTU JiRLMDS Joint Research Fund and Joint Research Funds for Medical and Engineering and Scientific Research at Shanghai Jiao Tong University (YG2021ZD02).</p>
  </sec>
  <sec sec-type="COI-statement" id="s9">
    <title>Conflict of interest</title>
    <p>The authors declare no conflict of interest.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="R1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sung</surname><given-names>H.</given-names></string-name>, <string-name><surname>Ferlay</surname><given-names>J.</given-names></string-name>, <string-name><surname>Siegel</surname><given-names>R.L.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>. <source><italic toggle="yes">CA Cancer J. Clin.</italic></source>, <volume>71</volume>, <fpage>209</fpage>–<lpage>249</lpage>.<pub-id pub-id-type="pmid">33538338</pub-id></mixed-citation>
    </ref>
    <ref id="R2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bandla</surname><given-names>S.</given-names></string-name>, <string-name><surname>Pennathur</surname><given-names>A.</given-names></string-name>, <string-name><surname>Luketich</surname><given-names>J.D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma</article-title>. <source><italic toggle="yes">Ann. Thorac. Surg.</italic></source>, <volume>93</volume>, <fpage>1101</fpage>–<lpage>1106</lpage>.<pub-id pub-id-type="pmid">22450065</pub-id></mixed-citation>
    </ref>
    <ref id="R3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Navab</surname><given-names>F.</given-names></string-name>, <string-name><surname>Nathanson</surname><given-names>B.H.</given-names></string-name> and <string-name><surname>Desilets</surname><given-names>D.J.</given-names></string-name></person-group> (<year>2015</year>) <article-title>The impact of lifestyle on Barrett’s esophagus: a precursor to esophageal adenocarcinoma</article-title>. <source><italic toggle="yes">Cancer Epidemiol.</italic></source>, <volume>39</volume>, <fpage>885</fpage>–<lpage>891</lpage>.<pub-id pub-id-type="pmid">26519660</pub-id></mixed-citation>
    </ref>
    <ref id="R4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Network</surname><given-names>C.G.A.R.</given-names></string-name></person-group><etal>et al.</etal> (<year>2017</year>) <article-title>Integrated genomic characterization of oesophageal carcinoma</article-title>. <source><italic toggle="yes">Nature</italic></source>, <volume>541</volume>, <fpage>169</fpage>–<lpage>175</lpage>.<pub-id pub-id-type="pmid">28052061</pub-id></mixed-citation>
    </ref>
    <ref id="R5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Arnal</surname><given-names>M.J.D.</given-names></string-name>, <string-name><surname>Arenas</surname><given-names>Á.F.</given-names></string-name> and <string-name><surname>Arbeloa</surname><given-names>Á.L.</given-names></string-name></person-group> (<year>2015</year>) <article-title>Esophageal cancer: risk factors, screening and endoscopic treatment in western and eastern countries</article-title>. <source><italic toggle="yes">World J. Gastroenterol.</italic></source>, <volume>21</volume>, <fpage>7933</fpage>–<lpage>7943</lpage>.<pub-id pub-id-type="pmid">26185366</pub-id></mixed-citation>
    </ref>
    <ref id="R6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Griffiths-Jones</surname><given-names>S.</given-names></string-name></person-group> (<year>2007</year>) <article-title>Annotating noncoding RNA genes</article-title>. <source><italic toggle="yes">Annu. Rev. Genomics Hum. Genet.</italic></source><volume>8</volume>, <fpage>279</fpage>–<lpage>298</lpage>.<pub-id pub-id-type="pmid">17506659</pub-id></mixed-citation>
    </ref>
    <ref id="R7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bartel</surname><given-names>D.P.</given-names></string-name></person-group> (<year>2009</year>) <article-title>MicroRNAs: target recognition and regulatory functions</article-title>. <source><italic toggle="yes">Cell</italic></source>, <volume>136</volume>, <fpage>215</fpage>–<lpage>233</lpage>.<pub-id pub-id-type="pmid">19167326</pub-id></mixed-citation>
    </ref>
    <ref id="R8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>B.</given-names></string-name>, <string-name><surname>Pan</surname><given-names>X.</given-names></string-name>, <string-name><surname>Cobb</surname><given-names>G.P.</given-names></string-name></person-group><etal>et al.</etal> (<year>2007</year>) <article-title>MicroRNAs as oncogenes and tumor suppressors</article-title>. <source><italic toggle="yes">Dev. Biol.</italic></source>, <volume>302</volume>, <fpage>1</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">16989803</pub-id></mixed-citation>
    </ref>
    <ref id="R9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lynam-Lennon</surname><given-names>N.</given-names></string-name>, <string-name><surname>Maher</surname><given-names>S.G.</given-names></string-name> and <string-name><surname>Reynolds</surname><given-names>J.V.</given-names></string-name></person-group> (<year>2009</year>) <article-title>The roles of microRNA in cancer and apoptosis</article-title>. <source><italic toggle="yes">Biol. Rev.</italic></source>, <volume>84</volume>, <fpage>55</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">19046400</pub-id></mixed-citation>
    </ref>
    <ref id="R10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tutar</surname><given-names>L.</given-names></string-name>, <string-name><surname>Tutar</surname><given-names>E.</given-names></string-name> and <string-name><surname>Tutar</surname><given-names>Y.</given-names></string-name></person-group> (<year>2014</year>) <article-title>MicroRNAs and cancer; an overview</article-title>. <source><italic toggle="yes">Curr. Pharm. Biotechnol.</italic></source>, <volume>15</volume>, <fpage>430</fpage>–<lpage>437</lpage>.<pub-id pub-id-type="pmid">24846068</pub-id></mixed-citation>
    </ref>
    <ref id="R11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Calin</surname><given-names>G.A.</given-names></string-name>, <string-name><surname>Sevignani</surname><given-names>C.</given-names></string-name>, <string-name><surname>Dumitru</surname><given-names>C.D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2004</year>) <article-title>Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers</article-title>. <source><italic toggle="yes">Proc. Natl. Acad. Sci. U.S.A.</italic></source>, <volume>101</volume>, <fpage>2999</fpage>–<lpage>3004</lpage>.<pub-id pub-id-type="pmid">14973191</pub-id></mixed-citation>
    </ref>
    <ref id="R12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abbas</surname><given-names>G.</given-names></string-name> and <string-name><surname>Krasna</surname><given-names>M.</given-names></string-name></person-group> (<year>2017</year>) <article-title>Overview of esophageal cancer</article-title>. <source><italic toggle="yes">Ann. Cardiothorac. Surg.</italic></source>, <volume>6</volume>, <fpage>131</fpage>–<lpage>136</lpage>.<pub-id pub-id-type="pmid">28447001</pub-id></mixed-citation>
    </ref>
    <ref id="R13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>X.</given-names></string-name>, <string-name><surname>Duan</surname><given-names>N.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>C.</given-names></string-name></person-group><etal>et al.</etal> (<year>2016</year>) <article-title>Survivin and tumorigenesis: molecular mechanisms and therapeutic strategies</article-title>. <source><italic toggle="yes">J. Cancer</italic></source>, <volume>7</volume>, <fpage>314</fpage>–<lpage>323</lpage>.<pub-id pub-id-type="pmid">26918045</pub-id></mixed-citation>
    </ref>
    <ref id="R14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sethi</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ali</surname><given-names>S.</given-names></string-name>, <string-name><surname>Philip</surname><given-names>P.A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2013</year>) <article-title>Clinical advances in molecular biomarkers for cancer diagnosis and therapy</article-title>. <source><italic toggle="yes">Int. J. Mol. Sci.</italic></source>, <volume>14</volume>, <fpage>14771</fpage>–<lpage>14784</lpage>.<pub-id pub-id-type="pmid">23863689</pub-id></mixed-citation>
    </ref>
    <ref id="R15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hassanein</surname><given-names>M.</given-names></string-name>, <string-name><surname>Callison</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Callaway-Lane</surname><given-names>C.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>The state of molecular biomarkers for the early detection of lung cancer</article-title>. <source><italic toggle="yes">Cancer Prevent. Res.</italic></source>, <volume>5</volume>, <fpage>992</fpage>–<lpage>1006</lpage>.</mixed-citation>
    </ref>
    <ref id="R16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tsuchiya</surname><given-names>N.</given-names></string-name>, <string-name><surname>Sawada</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Endo</surname><given-names>I.</given-names></string-name></person-group><etal>et al.</etal> (<year>2015</year>) <article-title>Biomarkers for the early diagnosis of hepatocellular carcinoma</article-title>. <source><italic toggle="yes">World J. Gastroenterol.</italic></source>, <volume>21</volume>, <fpage>10573</fpage>–<lpage>10583</lpage>.<pub-id pub-id-type="pmid">26457017</pub-id></mixed-citation>
    </ref>
    <ref id="R17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nangraj</surname><given-names>A.S.</given-names></string-name>, <string-name><surname>Selvaraj</surname><given-names>G.</given-names></string-name>, <string-name><surname>Kaliamurthi</surname><given-names>S.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>Integrated PPI- and WGCNA-retrieval of hub gene signatures shared between Barrett’s esophagus and esophageal adenocarcinoma</article-title>. <source><italic toggle="yes">Front. Pharmacol.</italic></source>, <volume>11</volume>, <fpage>1</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">32116689</pub-id></mixed-citation>
    </ref>
    <ref id="R18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Wei</surname><given-names>Y.K.</given-names></string-name>, <string-name><surname>Kaliamurthi</surname><given-names>S.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>Circulating mir-1246 targeting UBE2C, TNNI3, TRAIP, UCHL1 genes and key pathways as a potential biomarker for lung adenocarcinoma: integrated biological network analysis</article-title>. <source><italic toggle="yes">J. Pers. Med.</italic></source>, <volume>10</volume>, <fpage>1</fpage>–<lpage>20</lpage>.</mixed-citation>
    </ref>
    <ref id="R19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Yin</surname><given-names>H.</given-names></string-name>, <string-name><surname>Shi</surname><given-names>L.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>A novel microRNA signature for pathological grading in lung adenocarcinoma based on TCGA and GEO data</article-title>. <source><italic toggle="yes">Int. J. Mol. Med.</italic></source>, <volume>45</volume>, <fpage>1397</fpage>–<lpage>1408</lpage>.<pub-id pub-id-type="pmid">32323746</pub-id></mixed-citation>
    </ref>
    <ref id="R20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Kong</surname><given-names>D.</given-names></string-name>, <string-name><surname>Cui</surname><given-names>Q.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>Prognostic genes of breast cancer identified by gene co-expression network analysis</article-title>. <source><italic toggle="yes">Front. Oncol.</italic></source>, <volume>8</volume>, <page-range>374</page-range>.</mixed-citation>
    </ref>
    <ref id="R21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>He</surname><given-names>S.</given-names></string-name>, <string-name><surname>Shi</surname><given-names>J.</given-names></string-name>, <string-name><surname>Mao</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2019</year>) <article-title>The expression of mir-375 in prostate cancer: a study based on GEO, TCGA data and bioinformatics analysis</article-title>. <source><italic toggle="yes">Pathol. Res. Pract.</italic></source>, <volume>215</volume>, <fpage>1</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">30396757</pub-id></mixed-citation>
    </ref>
    <ref id="R22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rajewsky</surname><given-names>N.</given-names></string-name> and <string-name><surname>Socci</surname><given-names>N.D.</given-names></string-name></person-group> (<year>2004</year>) <article-title>Computational identification of microRNA targets</article-title>. <source><italic toggle="yes">Genome Biol.</italic></source>, <volume>5</volume>, <fpage>1</fpage>–<lpage>35</lpage>.</mixed-citation>
    </ref>
    <ref id="R23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Feber</surname><given-names>A.</given-names></string-name>, <string-name><surname>Xi</surname><given-names>L.</given-names></string-name>, <string-name><surname>Luketich</surname><given-names>J.D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2008</year>) <article-title>MicroRNA expression profiles of esophageal cancer</article-title>. <source><italic toggle="yes">J. Thorac. Cardiovasc. Surg.</italic></source>, <volume>135</volume>, <fpage>255</fpage>–<lpage>260</lpage>.<pub-id pub-id-type="pmid">18242245</pub-id></mixed-citation>
    </ref>
    <ref id="R24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>He</surname><given-names>B.</given-names></string-name>, <string-name><surname>Yin</surname><given-names>B.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>B.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>MicroRNAs in esophageal cancer</article-title>. <source><italic toggle="yes">Mol. Med. Rep.</italic></source>, <volume>6</volume>, <fpage>459</fpage>–<lpage>465</lpage>.<pub-id pub-id-type="pmid">22751839</pub-id></mixed-citation>
    </ref>
    <ref id="R25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harada</surname><given-names>K.</given-names></string-name>, <string-name><surname>Baba</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ishimoto</surname><given-names>T.</given-names></string-name></person-group><etal>et al.</etal> (<year>2016</year>) <article-title>The role of microRNA in esophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">J. Gastroenterol.</italic></source>, <volume>51</volume>, <fpage>520</fpage>–<lpage>530</lpage>.<pub-id pub-id-type="pmid">26794004</pub-id></mixed-citation>
    </ref>
    <ref id="R26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gao</surname><given-names>R.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Q.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>MicroRNA-105 plays an independent prognostic role in esophageal cancer and acts as an oncogene</article-title>. <source><italic toggle="yes">Cancer Biomark.</italic></source>, <volume>27</volume>, <fpage>173</fpage>–<lpage>180</lpage>.<pub-id pub-id-type="pmid">31796663</pub-id></mixed-citation>
    </ref>
    <ref id="R27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Garman</surname><given-names>K.S.</given-names></string-name>, <string-name><surname>Owzar</surname><given-names>K.</given-names></string-name>, <string-name><surname>Hauser</surname><given-names>E.R.</given-names></string-name></person-group><etal>et al.</etal> (<year>2013</year>) <article-title>MicroRNA expression differentiates squamous epithelium from Barrett’s esophagus and esophageal cancer</article-title>. <source><italic toggle="yes">Dig. Dis. Sci.</italic></source>, <volume>58</volume>, <fpage>3178</fpage>–<lpage>3188</lpage>.<pub-id pub-id-type="pmid">23925817</pub-id></mixed-citation>
    </ref>
    <ref id="R28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Griffiths-Jones</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Grocock</surname><given-names>S.</given-names></string-name>, <string-name><surname>Van Dongen</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2006</year>) <article-title>Enright, miRBase: microRNA sequences, targets and gene nomenclature</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>34</volume>, <fpage>D140</fpage>–<lpage>D144</lpage>.<pub-id pub-id-type="pmid">16381832</pub-id></mixed-citation>
    </ref>
    <ref id="R29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Georgakilas</surname><given-names>G.</given-names></string-name>, <string-name><surname>Vlachos</surname><given-names>I.S.</given-names></string-name>, <string-name><surname>Zagganas</surname><given-names>K.</given-names></string-name></person-group><etal>et al.</etal> (<year>2016</year>) <article-title>DIANA-miRGen v3.0: accurate characterization of microRNA promoters and their regulators</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>44</volume>, <fpage>D190</fpage>–<lpage>D195</lpage>.<pub-id pub-id-type="pmid">26586797</pub-id></mixed-citation>
    </ref>
    <ref id="R30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cho</surname><given-names>S.</given-names></string-name>, <string-name><surname>Jang</surname><given-names>I.</given-names></string-name>, <string-name><surname>Jun</surname><given-names>Y.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>Mirgator v3.0: a microRNA portal for deep sequencing, expression profiling and mRNA targeting</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>41</volume>, <fpage>D252</fpage>–<lpage>D257</lpage>.<pub-id pub-id-type="pmid">23193297</pub-id></mixed-citation>
    </ref>
    <ref id="R31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sticht</surname><given-names>C.</given-names></string-name>, <string-name><surname>De La Torre</surname><given-names>C.</given-names></string-name>, <string-name><surname>Parveen</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>miRWalk: an online resource for prediction of microRNA binding sites</article-title>. <source><italic toggle="yes">PLoS One</italic></source>, <volume>13</volume>, <fpage>1</fpage>–<lpage>6</lpage>.</mixed-citation>
    </ref>
    <ref id="R32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>H.Y.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>Y.C.D.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>miRTarBase 2020: updates to the experimentally validated microRNA–target interaction database</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>48</volume>, <fpage>D148</fpage>–<lpage>D154</lpage>.<pub-id pub-id-type="pmid">31647101</pub-id></mixed-citation>
    </ref>
    <ref id="R33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hsu</surname><given-names>P.W.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>H.D.</given-names></string-name>, <string-name><surname>Hsu</surname><given-names>S.D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2006</year>) <article-title>miRNAMap: genomic maps of microRNA genes and their target genes in mammalian genomes</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>1</volume>, <fpage>D135</fpage>–<lpage>D139</lpage>.</mixed-citation>
    </ref>
    <ref id="R34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xiao</surname><given-names>F.</given-names></string-name>, <string-name><surname>Zuo</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Cai</surname><given-names>G.</given-names></string-name></person-group><etal>et al.</etal> (<year>2009</year>) <article-title>miRecords: an integrated resource for microRNA–target interactions</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>37</volume>, <fpage>D105</fpage>–<lpage>D110</lpage>.<pub-id pub-id-type="pmid">18996891</pub-id></mixed-citation>
    </ref>
    <ref id="R35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Agarwal</surname><given-names>V.</given-names></string-name>, <string-name><surname>Bell</surname><given-names>G.W.</given-names></string-name>, <string-name><surname>Nam</surname><given-names>J.W.</given-names></string-name></person-group><etal>et al.</etal> (<year>2015</year>) <article-title>Predicting effective microRNA target sites in mammalian mRNAs</article-title>. <source><italic toggle="yes">eLife</italic></source>, <volume>4</volume>, <page-range>e05005</page-range>.</mixed-citation>
    </ref>
    <ref id="R36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wong</surname><given-names>N.</given-names></string-name> and <string-name><surname>Wang</surname><given-names>X.</given-names></string-name></person-group> (<year>2015</year>) <article-title>miRDB: an online resource for microRNA target prediction and functional annotations</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>43</volume>, <fpage>D146</fpage>–<lpage>D152</lpage>.<pub-id pub-id-type="pmid">25378301</pub-id></mixed-citation>
    </ref>
    <ref id="R37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Krek</surname><given-names>A.</given-names></string-name>, <string-name><surname>Grün</surname><given-names>D.</given-names></string-name>, <string-name><surname>Poy</surname><given-names>M.N.</given-names></string-name></person-group><etal>et al.</etal> (<year>2005</year>) <article-title>Combinatorial microRNA target predictions</article-title>. <source><italic toggle="yes">Nat. Genet.</italic></source>, <volume>37</volume>, <fpage>495</fpage>–<lpage>500</lpage>.<pub-id pub-id-type="pmid">15806104</pub-id></mixed-citation>
    </ref>
    <ref id="R38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Quillet</surname><given-names>A.</given-names></string-name>, <string-name><surname>Saad</surname><given-names>C.</given-names></string-name>, <string-name><surname>Ferry</surname><given-names>G.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>Improving bioinformatics prediction of microRNA targets by ranks aggregation</article-title>. <source><italic toggle="yes">Front. Genet.</italic></source>, <volume>10</volume>, <fpage>1</fpage>–<lpage>14</lpage>.</mixed-citation>
    </ref>
    <ref id="R39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Khurana</surname><given-names>R.</given-names></string-name>, <string-name><surname>Verma</surname><given-names>V.K.</given-names></string-name>, <string-name><surname>Rawoof</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>OncomiRdbB: a comprehensive database of microRNAs and their targets in breast cancer</article-title>. <source><italic toggle="yes">BMC Bioinform.</italic></source>, <volume>15</volume>, <fpage>1</fpage>–<lpage>12</lpage>.</mixed-citation>
    </ref>
    <ref id="R40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xie</surname><given-names>B.</given-names></string-name>, <string-name><surname>Ding</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Han</surname><given-names>H.</given-names></string-name></person-group><etal>et al.</etal> (<year>2013</year>) <article-title>miRCancer: a microRNA–cancer association database constructed by text mining on literature</article-title>. <source><italic toggle="yes">Bioinformatics</italic></source>, <volume>29</volume>, <fpage>638</fpage>–<lpage>644</lpage>.<pub-id pub-id-type="pmid">23325619</pub-id></mixed-citation>
    </ref>
    <ref id="R41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tan</surname><given-names>H.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>P.</given-names></string-name>, <string-name><surname>Sun</surname><given-names>P.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>miRactDB characterizes miRNA–gene relation switch between normal and cancer tissues across pan-cancer</article-title>. <source><italic toggle="yes">Brief. Bioinform.</italic></source>, <volume>22</volume>, <page-range>bbaa089</page-range>.</mixed-citation>
    </ref>
    <ref id="R42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ruepp</surname><given-names>A.</given-names></string-name>, <string-name><surname>Kowarsch</surname><given-names>A.</given-names></string-name>, <string-name><surname>Schmidl</surname><given-names>D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2010</year>) <article-title>PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes</article-title>. <source><italic toggle="yes">Genome Biol.</italic></source>, <volume>11</volume>, <fpage>1</fpage>–<lpage>11</lpage>.</mixed-citation>
    </ref>
    <ref id="R43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Qiu</surname><given-names>C.</given-names></string-name>, <string-name><surname>Tu</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>HMDD v2.0: a database for experimentally supported human microRNA and disease associations</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>42</volume>, <fpage>D1070</fpage>–<lpage>D1074</lpage>.<pub-id pub-id-type="pmid">24194601</pub-id></mixed-citation>
    </ref>
    <ref id="R44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sarver</surname><given-names>A.L.</given-names></string-name>, <string-name><surname>Phalak</surname><given-names>R.</given-names></string-name>, <string-name><surname>Thayanithy</surname><given-names>V.</given-names></string-name></person-group><etal>et al.</etal> (<year>2010</year>) <article-title>S-MED: sarcoma microRNA expression database</article-title>. <source><italic toggle="yes">Lab. Invest.</italic></source>, <volume>90</volume>, <fpage>753</fpage>–<lpage>761</lpage>.<pub-id pub-id-type="pmid">20212452</pub-id></mixed-citation>
    </ref>
    <ref id="R45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hao</surname><given-names>Y.</given-names></string-name></person-group><etal>et al.</etal> (<year>2009</year>) <article-title>mir2disease: a manually curated database for microRNA deregulation in human disease</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>37</volume>, <fpage>D98</fpage>–<lpage>D104</lpage>.<pub-id pub-id-type="pmid">18927107</pub-id></mixed-citation>
    </ref>
    <ref id="R46">
      <label>46.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname><given-names>T.P.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>C.Y.</given-names></string-name>, <string-name><surname>Tsai</surname><given-names>M.H.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>miRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets</article-title>. <source><italic toggle="yes">PLoS One</italic></source>, <volume>7</volume>, <fpage>1</fpage>–<lpage>14</lpage>.</mixed-citation>
    </ref>
    <ref id="R47">
      <label>47.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Forbes</surname><given-names>S.</given-names></string-name>, <string-name><surname>Clements</surname><given-names>J.</given-names></string-name>, <string-name><surname>Dawson</surname><given-names>E.</given-names></string-name></person-group><etal>et al.</etal> (<year>2006</year>) <article-title>COSMIC 2005</article-title>. <source><italic toggle="yes">Br. J. Cancer</italic></source>, <volume>94</volume>, <fpage>318</fpage>–<lpage>322</lpage>.<pub-id pub-id-type="pmid">16421597</pub-id></mixed-citation>
    </ref>
    <ref id="R48">
      <label>48.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kanehisa</surname><given-names>M.</given-names></string-name> and <string-name><surname>Goto</surname><given-names>S.</given-names></string-name></person-group> (<year>2000</year>) <article-title>KEGG: Kyoto Encyclopedia of Genes and Genomes</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>28</volume>, <fpage>27</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">10592173</pub-id></mixed-citation>
    </ref>
    <ref id="R49">
      <label>49.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Essack</surname><given-names>M.</given-names></string-name>, <string-name><surname>Radovanovic</surname><given-names>A.</given-names></string-name>, <string-name><surname>Schaefer</surname><given-names>U.</given-names></string-name></person-group><etal>et al.</etal> (<year>2009</year>) <article-title>DDEC: Dragon database of genes implicated in esophageal cancer</article-title>. <source><italic toggle="yes">BMC Cancer</italic></source>, <volume>9</volume>, <fpage>1</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">19118499</pub-id></mixed-citation>
    </ref>
    <ref id="R50">
      <label>50.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kato</surname><given-names>K.</given-names></string-name>, <string-name><surname>Yamashita</surname><given-names>R.</given-names></string-name>, <string-name><surname>Matoba</surname><given-names>R.</given-names></string-name></person-group><etal>et al.</etal> (<year>2005</year>) <article-title>Cancer gene expression database (CGED): a database for gene expression profiling with accompanying clinical information of human cancer tissues</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>33</volume>, <fpage>D533</fpage>–<lpage>D536</lpage>.<pub-id pub-id-type="pmid">15608255</pub-id></mixed-citation>
    </ref>
    <ref id="R51">
      <label>51.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Piñero</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ramírez-Anguita</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Saüch-Pitarch</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>The DisGeNET knowledge platform for disease genomics: 2019 update</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>48</volume>, <fpage>D845</fpage>–<lpage>D855</lpage>.<pub-id pub-id-type="pmid">31680165</pub-id></mixed-citation>
    </ref>
    <ref id="R52">
      <label>52.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kinsella</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Kähäri</surname><given-names>A.</given-names></string-name>, <string-name><surname>Haider</surname><given-names>S.</given-names></string-name></person-group><etal>et al.</etal> (<year>2011</year>) <article-title>Ensembl BioMarts: a hub for data retrieval across taxonomic space</article-title>. <source><italic toggle="yes">Database</italic></source>, <volume>2011</volume>, <page-range>bar030</page-range>.</mixed-citation>
    </ref>
    <ref id="R53">
      <label>53.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miranda</surname><given-names>K.C.</given-names></string-name>, <string-name><surname>Huynh</surname><given-names>T.</given-names></string-name>, <string-name><surname>Tay</surname><given-names>Y.</given-names></string-name></person-group><etal>et al.</etal> (<year>2006</year>) <article-title>A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes</article-title>. <source><italic toggle="yes">Cell</italic></source>, <volume>126</volume>, <fpage>1203</fpage>–<lpage>1217</lpage>.<pub-id pub-id-type="pmid">16990141</pub-id></mixed-citation>
    </ref>
    <ref id="R54">
      <label>54.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Paraskevopoulou</surname><given-names>M.D.</given-names></string-name>, <string-name><surname>Georgakilas</surname><given-names>G.</given-names></string-name>, <string-name><surname>Kostoulas</surname><given-names>N.</given-names></string-name></person-group><etal>et al.</etal> (<year>2013</year>) <article-title>DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>41</volume>, <fpage>W169</fpage>–<lpage>W173</lpage>.<pub-id pub-id-type="pmid">23680784</pub-id></mixed-citation>
    </ref>
    <ref id="R55">
      <label>55.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>You</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>D.</given-names></string-name>, <string-name><surname>Ji</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">Clin. Transl. Oncol.</italic></source>, <volume>14</volume>, <fpage>143</fpage>–<lpage>149</lpage>.<pub-id pub-id-type="pmid">22301404</pub-id></mixed-citation>
    </ref>
    <ref id="R56">
      <label>56.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meng</surname><given-names>X.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>P.</given-names></string-name>, <string-name><surname>Mei</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>Expression analysis of miRNA and target mRNAs in esophageal cancer</article-title>. <source><italic toggle="yes">Braz. J. Med. Biol. Res.</italic></source>, <volume>47</volume>, <fpage>811</fpage>–<lpage>817</lpage>.<pub-id pub-id-type="pmid">25098614</pub-id></mixed-citation>
    </ref>
    <ref id="R57">
      <label>57.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cheng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Geng</surname><given-names>H.</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>Y.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>Effects of MiR-210 on proliferation, apoptosis and invasion abilities of esophageal cancer cells</article-title>. <source><italic toggle="yes">J. BUON</italic></source>, <volume>23</volume>, <fpage>814</fpage>–<lpage>819</lpage>.<pub-id pub-id-type="pmid">30003756</pub-id></mixed-citation>
    </ref>
    <ref id="R58">
      <label>58.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Javadinia</surname><given-names>S.A.</given-names></string-name>, <string-name><surname>Shahidsales</surname><given-names>S.</given-names></string-name>, <string-name><surname>Fanipakdel</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>The esophageal cancer and the PI3K/AKT/mTOR signaling regulatory microRNAs: a novel marker for prognosis, and a possible target for immunotherapy</article-title>. <source><italic toggle="yes">Curr. Pharm. Des.</italic></source>, <volume>24</volume>, <fpage>4646</fpage>–<lpage>4651</lpage>.<pub-id pub-id-type="pmid">30636576</pub-id></mixed-citation>
    </ref>
    <ref id="R59">
      <label>59.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Akbarzadeh</surname><given-names>M.</given-names></string-name>, <string-name><surname>Mihanfar</surname><given-names>A.</given-names></string-name>, <string-name><surname>Akbarzadeh</surname><given-names>S.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer</article-title>. <source><italic toggle="yes">Life Sci.</italic></source>, <volume>285</volume>, <fpage>1</fpage>–<lpage>14</lpage>.</mixed-citation>
    </ref>
    <ref id="R60">
      <label>60.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Sun</surname><given-names>K.</given-names></string-name>, <string-name><surname>Chu</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>Long non-coding RNA FTH1P3 regulated metastasis and invasion of esophageal squamous cell carcinoma through SP1/NF-kB pathway</article-title>. <source><italic toggle="yes">Biomed. Pharmacother.</italic></source>, <volume>106</volume>, <fpage>1570</fpage>–<lpage>1577</lpage>.<pub-id pub-id-type="pmid">30119232</pub-id></mixed-citation>
    </ref>
    <ref id="R61">
      <label>61.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Chang</surname><given-names>W.</given-names></string-name></person-group><etal>et al.</etal> (<year>2019</year>) <article-title>MicroRNA-373 promotes the development of esophageal squamous cell carcinoma by targeting <italic toggle="yes">LATS2</italic> and <italic toggle="yes">OXR1</italic></article-title>. <source><italic toggle="yes">Int. J. Biol. Markers</italic></source>, <volume>34</volume>, <fpage>148</fpage>–<lpage>155</lpage>.<pub-id pub-id-type="pmid">30852977</pub-id></mixed-citation>
    </ref>
    <ref id="R62">
      <label>62.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Pan</surname><given-names>T.</given-names></string-name>, <string-name><surname>Zhong</surname><given-names>X.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>Nicotine upregulates microRNA-21 and promotes TGF-<italic toggle="yes">β</italic>-dependent epithelial-mesenchymal transition of esophageal cancer cells</article-title>. <source><italic toggle="yes">Tumor Biol.</italic></source>, <volume>35</volume>, <fpage>7063</fpage>–<lpage>7072</lpage>.</mixed-citation>
    </ref>
    <ref id="R63">
      <label>63.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jia</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhan</surname><given-names>Q.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer</article-title>. <source><italic toggle="yes">J. Mol. Diagn.</italic></source>, <volume>14</volume>, <fpage>577</fpage>–<lpage>585</lpage>.<pub-id pub-id-type="pmid">22921431</pub-id></mixed-citation>
    </ref>
    <ref id="R64">
      <label>64.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>R.</given-names></string-name> and <string-name><surname>Liu</surname><given-names>X.-L.</given-names></string-name></person-group> (<year>2022</year>) <article-title>Roles of Wnt/<italic toggle="yes">β</italic>-catenin signaling pathway related microRNAs in esophageal cancer</article-title>. <source><italic toggle="yes">World J. Clin. Cases</italic></source>, <volume>10</volume>, <fpage>2678</fpage>–<lpage>2686</lpage>.<pub-id pub-id-type="pmid">35434118</pub-id></mixed-citation>
    </ref>
    <ref id="R65">
      <label>65.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Subramaniam</surname><given-names>D.</given-names></string-name>, <string-name><surname>Ponnurangam</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ramamoorthy</surname><given-names>P.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>Curcumin induces cell death in esophageal cancer cells through modulating notch signaling</article-title>. <source><italic toggle="yes">PLoS One</italic></source>, <volume>7</volume>, <fpage>1</fpage>–<lpage>11</lpage>.</mixed-citation>
    </ref>
    <ref id="R66">
      <label>66.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Roychowdhury</surname><given-names>D.</given-names></string-name>, <string-name><surname>Gupta</surname><given-names>S.</given-names></string-name>, <string-name><surname>Qin</surname><given-names>X.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>emiRIT: a text-mining-based resource for microRNA information</article-title>. <source><italic toggle="yes">Database</italic></source>, <volume>2021</volume>, <fpage>1</fpage>–<lpage>20</lpage>.</mixed-citation>
    </ref>
    <ref id="R67">
      <label>67.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ritchie</surname><given-names>W.</given-names></string-name>, <string-name><surname>Flamant</surname><given-names>S.</given-names></string-name> and <string-name><surname>Rasko</surname><given-names>J.E.</given-names></string-name></person-group> (<year>2009</year>) <article-title>Predicting microRNA targets and functions: traps for the unwary</article-title>. <source><italic toggle="yes">Nat. Methods</italic></source>, <volume>6</volume>, <fpage>397</fpage>–<lpage>398</lpage>.<pub-id pub-id-type="pmid">19478799</pub-id></mixed-citation>
    </ref>
    <ref id="R68">
      <label>68.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lewis</surname><given-names>B.P.</given-names></string-name>, <string-name><surname>Shih</surname><given-names>I.H.</given-names></string-name>, <string-name><surname>Jones-Rhoades</surname><given-names>M.W.</given-names></string-name></person-group><etal>et al.</etal> (<year>2003</year>) <article-title>Prediction of mammalian microRNA targets</article-title>. <source><italic toggle="yes">Cell</italic></source>, <volume>115</volume>, <fpage>787</fpage>–<lpage>798</lpage>.<pub-id pub-id-type="pmid">14697198</pub-id></mixed-citation>
    </ref>
    <ref id="R69">
      <label>69.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xu</surname><given-names>W.</given-names></string-name>, <string-name><surname>San Lucas</surname><given-names>A.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>Identifying microRNA targets in different gene regions</article-title>. <source><italic toggle="yes">BMC Bioinform.</italic></source>, <volume>15</volume>, <fpage>1</fpage>–<lpage>11</lpage>.</mixed-citation>
    </ref>
    <ref id="R70">
      <label>70.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name> and <string-name><surname>Chen</surname><given-names>X.</given-names></string-name></person-group> (<year>2021</year>) <article-title>NOTCH and esophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">Adv Exp Med Biol</italic></source>, <volume>1287</volume>, <fpage>59</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="pmid">33034026</pub-id></mixed-citation>
    </ref>
    <ref id="R71">
      <label>71.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Yi</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>K.</given-names></string-name></person-group><etal>et al.</etal> (<year>2017</year>) <article-title>Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">J. Exp. Clin. Cancer Res.</italic></source>, <volume>36</volume>, <fpage>1</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">28049532</pub-id></mixed-citation>
    </ref>
    <ref id="R72">
      <label>72.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>Q.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>MiR-34a-5p inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in esophageal squamous cell carcinoma by targeting lef1 and inactivation of the Hippo-YAP1/TAZ signaling pathway</article-title>. <source><italic toggle="yes">J. Cancer</italic></source>, <volume>11</volume>, <fpage>3072</fpage>–<lpage>3081</lpage>.<pub-id pub-id-type="pmid">32226522</pub-id></mixed-citation>
    </ref>
    <ref id="R73">
      <label>73.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>Y.R.</given-names></string-name>, <string-name><surname>Qi</surname><given-names>H.J.</given-names></string-name>, <string-name><surname>Deng</surname><given-names>D.F.</given-names></string-name></person-group><etal>et al.</etal> (<year>2016</year>) <article-title>MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer</article-title>. <source><italic toggle="yes">Tumor Biol.</italic></source>, <volume>37</volume>, <fpage>12061</fpage>–<lpage>12070</lpage>.</mixed-citation>
    </ref>
    <ref id="R74">
      <label>74.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Izzo</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>T.</given-names></string-name>, <string-name><surname>Malhotra</surname><given-names>U.</given-names></string-name></person-group><etal>et al.</etal> (<year>2006</year>) <article-title>Transcription factor NFkB a potential molecular marker for predicting and improving treatment efficacy in esophageal cancer</article-title>. <source><italic toggle="yes">J. Clin. Oncol.</italic></source>, <volume>24</volume>, <fpage>10065</fpage>–<lpage>10065</lpage>.</mixed-citation>
    </ref>
    <ref id="R75">
      <label>75.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>K.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>X.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells</article-title>. <source><italic toggle="yes">BMC Mol. Biol.</italic></source>, <volume>13</volume>, <fpage>1</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">22248237</pub-id></mixed-citation>
    </ref>
    <ref id="R76">
      <label>76.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Naganuma</surname><given-names>S.</given-names></string-name>, <string-name><surname>Whelan</surname><given-names>K.A.</given-names></string-name>, <string-name><surname>Natsuizaka</surname><given-names>M.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>Notch receptor inhibition reveals the importance of cyclin D1 and Wnt signaling in invasive esophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">Am. J. Cancer Res.</italic></source>, <volume>2</volume>, <fpage>459</fpage>–<lpage>475</lpage>.<pub-id pub-id-type="pmid">22860235</pub-id></mixed-citation>
    </ref>
    <ref id="R77">
      <label>77.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Qi</surname><given-names>B.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Z.J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2017</year>) <article-title>Down-regulation of miR-30a-3p/5p promotes esophageal squamous cell carcinoma cell proliferation by activating the Wnt signaling pathway</article-title>. <source><italic toggle="yes">World J. Gastroenterol.</italic></source>, <volume>23</volume>, <fpage>7965</fpage>–<lpage>7977</lpage>.<pub-id pub-id-type="pmid">29259372</pub-id></mixed-citation>
    </ref>
    <ref id="R78">
      <label>78.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kano</surname><given-names>M.</given-names></string-name>, <string-name><surname>Seki</surname><given-names>N.</given-names></string-name>, <string-name><surname>Kikkawa</surname><given-names>N.</given-names></string-name></person-group><etal>et al.</etal> (<year>2010</year>) <article-title>miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">Int. J. Cancer</italic></source>, <volume>127</volume>, <fpage>2804</fpage>–<lpage>2814</lpage>.<pub-id pub-id-type="pmid">21351259</pub-id></mixed-citation>
    </ref>
    <ref id="R79">
      <label>79.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matsushima</surname><given-names>K.</given-names></string-name>, <string-name><surname>Isomoto</surname><given-names>H.</given-names></string-name>, <string-name><surname>Kohno</surname><given-names>S.</given-names></string-name></person-group><etal>et al.</etal> (<year>2010</year>) <article-title>MicroRNAs and esophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">Digestion</italic></source>, <volume>82</volume>, <fpage>138</fpage>–<lpage>144</lpage>.<pub-id pub-id-type="pmid">20588024</pub-id></mixed-citation>
    </ref>
    <ref id="R80">
      <label>80.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ma</surname><given-names>W.J.</given-names></string-name>, <string-name><surname>Lv</surname><given-names>G.D.</given-names></string-name>, <string-name><surname>Tuersun</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2011</year>) <article-title>Role of microRNA-21 and effect on PTEN in Kazakh’s esophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">Mol. Biol. Rep.</italic></source>, <volume>38</volume>, <fpage>3253</fpage>–<lpage>3260</lpage>.<pub-id pub-id-type="pmid">21104017</pub-id></mixed-citation>
    </ref>
    <ref id="R81">
      <label>81.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matsushima</surname><given-names>K.</given-names></string-name>, <string-name><surname>Isomoto</surname><given-names>H.</given-names></string-name>, <string-name><surname>Yamaguchi</surname><given-names>N.</given-names></string-name></person-group><etal>et al.</etal> (<year>2011</year>) <article-title>miRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells</article-title>. <source><italic toggle="yes">J. Transl. Med.</italic></source>, <volume>9</volume>, <fpage>1</fpage>–<lpage>12</lpage>.</mixed-citation>
    </ref>
    <ref id="R82">
      <label>82.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vecchione</surname><given-names>A.</given-names></string-name>, <string-name><surname>Croce</surname><given-names>C.M.</given-names></string-name> and <string-name><surname>Baldassarre</surname><given-names>G.</given-names></string-name></person-group> (<year>2007</year>) <article-title>Fez1/Lzts1 a new mitotic regulator implicated in cancer development</article-title>. <source><italic toggle="yes">Cell Div.</italic></source>, <volume>2</volume>, <fpage>1</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">17214889</pub-id></mixed-citation>
    </ref>
    <ref id="R83">
      <label>83.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shi</surname><given-names>H.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>R.</given-names></string-name></person-group><etal>et al.</etal> (<year>2016</year>) <article-title>FGF2 regulates proliferation, migration, and invasion of ECA109 cells through PI3K/Akt signalling pathway in vitro</article-title>. <source><italic toggle="yes">Cell Biol. Int.</italic></source>, <volume>40</volume>, <fpage>524</fpage>–<lpage>533</lpage>.<pub-id pub-id-type="pmid">26833879</pub-id></mixed-citation>
    </ref>
    <ref id="R84">
      <label>84.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lui Park</surname><given-names>H.</given-names></string-name>, <string-name><surname>Sook Kim</surname><given-names>M.</given-names></string-name>, <string-name><surname>Yamashita</surname><given-names>K.</given-names></string-name></person-group><etal>et al.</etal> (<year>2008</year>) <article-title>DCC promoter hypermethylation in esophageal squamous cell carcinoma</article-title>. <source><italic toggle="yes">Int. J. Cancer</italic></source>, <volume>122</volume>, <fpage>2498</fpage>–<lpage>2502</lpage>.<pub-id pub-id-type="pmid">18302152</pub-id></mixed-citation>
    </ref>
    <ref id="R85">
      <label>85.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>X.J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>D.Y.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Y.</given-names></string-name></person-group><etal>et al.</etal> (<year>1999</year>) <article-title>Mxi1 mutations in human neurofibrosarcomas</article-title>. <source><italic toggle="yes">Jpn. J. Cancer Res.</italic></source>, <volume>90</volume>, <fpage>740</fpage>–<lpage>746</lpage>.<pub-id pub-id-type="pmid">10470286</pub-id></mixed-citation>
    </ref>
    <ref id="R86">
      <label>86.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname><given-names>N.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>C.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>Y.</given-names></string-name></person-group><etal>et al.</etal> (<year>2005</year>) <article-title>Genome-wide association study in esophageal cancer using GeneChip mapping 10k array</article-title>. <source><italic toggle="yes">Cancer Res.</italic></source>, <volume>65</volume>, <fpage>2542</fpage>–<lpage>2546</lpage>.<pub-id pub-id-type="pmid">15805246</pub-id></mixed-citation>
    </ref>
    <ref id="R87">
      <label>87.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jin</surname><given-names>G.</given-names></string-name>, <string-name><surname>Deng</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Miao</surname><given-names>R.</given-names></string-name></person-group><etal>et al.</etal> (<year>2008</year>) <article-title>TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case–control analysis in a Chinese population</article-title>. <source><italic toggle="yes">J. Cancer Res. Clin. Oncol.</italic></source>, <volume>134</volume>, <fpage>345</fpage>–<lpage>351</lpage>.<pub-id pub-id-type="pmid">17680270</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
